P61769 (B2MG_HUMAN) Homo sapiens (Human)

Beta-2-microglobulin UniProtKBInterProSTRINGInteractive Modelling

119 aa; Sequence (Fasta) ; 5 identical sequences: Pongo pygmaeus: P16213; Pan troglodytes: P61770, A0A2J8NTN7; Pan paniscus: A0A2R8ZGZ1; Gorilla gorilla gorilla: P61771

Available Structures

1216 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structure of 5F3 TCR in complex with HLA-A2/MART-1 Heteromer
P04439; Q6PJ56;
4-119
50.0NAG;
Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide Heteromer
P01889; P48735;
19-119
100K;NA;
Crystal structure of HLA-A3*01 in complex with a wild-type beta-catenin peptide Heteromer
P04439; P35222;
19-119
100PG4;MES;IMD;PEG;EDO;
Crystal structure of HLA-B*07:02 with wild-type IDH2 peptide Heteromer
P01889; P48735;
19-119
100PEG;1PE;SO4;PGE;
Structure of KRAS WT(7-16)-HLA-A*03:01 Heteromer
P01116; P04439;
19-119
10013×SO4;PEG;
Structure of KRAS G12V/HLA-A*03:01 in complex with antibody fragment V2 Heteromer
P01116; P04439;
19-119
100
Crystal structure of HLA-C*1402 complexed with 8-mer HIV gag peptide Heteromer
A0A858LG55; P04591;
20-119
100EDO;NA;ACT;
Crystal structure of HLA-C*1402 complexed with 4-mer lipopeptide Heteromer
A0A858LG55;
20-119
10018×EDO;MYR;
TCR F50 recgonizing M1-HLA-A2 Heteromer
P03485; P04439;
20-119
100
CD1c with antigen analogue 1 Heteromer
P29016; P29017;
20-119
100NAG;ZPD;D12;ZP7;NHE;MLA;
HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV… Heteromer
P04439;
20-119
99.0
Crystal structure of HLA-A*2402 complexed with 4-mer lipopeptide Heteromer
A0A5H2UYS3;
20-119
100TRS;ACT;ZN; 26×EDO;
Crystal structure of HLA-A*2402 complexed with 8-mer Influenza PB1 peptide Heteromer
A0A5H2UYS3; Q9WLS3;
20-119
10033×EDO;ZN;TRS;ACT;
CD1c with antigen analogue 2 Heteromer
P29016; P29017;
20-119
100NAG;NHE;ZQ4;D12;ZP7;MLA;
A T cell receptor in complex with HLA-A0201 restricted Hepatitis C virus NS3 peptide (KLVALGINAV) Heteromer
P04439; P27958;
20-119
97.0
Crystal structure of HLA-A*2450 complexed with 8-mer model peptide Heteromer
A0A109QAI7; Q9WLS3;
20-119
100ZN;TRS; 35×EDO;
CD1c with antigen analogue 3 Heteromer
P29016; P29017;
20-119
100NAG;ZQ7;D12;ZP7;MLA;
CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX Heteromer
P04439;
20-119
99.0
Mouse MHC class I H-2Kd with a MERS-CoV-derived peptide I5A Heteromer
K9N5Q8; P01902;
20-119
100
POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTE… Heteromer
P04439; P04626;
20-119
99.0
Crystal structure of HLA-A3*01 in complex with a mutant beta-catenin peptide Heteromer
P04439; P35222;
20-119
100MES; 10×SO4;PEG;
Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions wit… Heteromer
P30511;
20-119
99.0
STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R Heteromer
P04439;
20-119
99.0
STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A Heteromer
P01848; P04439;
20-119
99.0
Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab Heteromer
P01889; P48735;
20-119
100PEG;NHE;SO4;
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P04439;
20-119
100
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P04439;
20-119
100
HLA-B*2709 BOUND TO NONA-PEPTIDE M9 Heteromer
P01889;
21-119
100GOL;
Crystal Structure of MHC class I HLA-A2 molecule complexed with EBV bmlf1-280-288 nonapeptide Heteromer
P04439; Q3KSU1;
21-119
100
Structures of HLA-B8E76C loaded with long peptides reveal novel features at the N-terminus of the g… Heteromer
Q5SS57;
21-119
100
Crystal structure of HLA B*18:01 in complex with QEIRTFSF, an 8-mer epitope from Influenza A Heteromer
Q76MT9; S6AU73;
21-119
100EDO;CL;NA;
Crystal structure of HLA-B*5301 complex with an HIV-1 Gag-derived epitope QW9 S3T variant Heteromer
O91080; S6BVK3;
21-119
100
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P01889; P03407;
21-119
10026×EDO;GOL;
Crystal structure of HLA-B*2709 complexed with the glucagon receptor (GR) peptide (residues 412-420) Heteromer
P01889; P47871;
21-119
100GOL;
Crystal structure of HLA-B2705 complexed with the nona-peptide mA Heteromer
A0A6B7HFJ9;
21-119
100GOL;CL;
Crystal Structure of HLA-B*18:01 in complex with NP338 influenza peptide Heteromer
P01889;
21-119
100
Structures of HLA-B8E76C loaded with long peptides reveal novel features at the N-terminus of the g… Heteromer
Q5SS57;
21-119
100
Crystal structure of HLA-B*44:05 (T73C) with 9mer EEFGRAFSF Heteromer
D5H3J5; Q9TQB0;
21-119
100GOL;EDO;
Crystal structure of HLA-B2705 complexed with the nona-peptide mQ Heteromer
A0A6B7HFJ9;
21-119
100GOL;
HLA-B*57:01 presenting the peptide ASLNLPAVSW Heteromer
P35221; U6BR87;
21-119
100ACT;
Crystal structure of HLA-B2709 complexed with the nona-peptide mE Heteromer
A0A2R7Z5J3;
21-119
100GOL;
Crystal structure of HLA-B*4103 in complex with a 16mer self-peptide derived from heterogeneous nuc… Heteromer
P01889; P07910;
21-119
100ACT;
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide Heteromer
P04439; Q03463;
21-119
100CIT;
Crystal structure of a peptide-HLA complex Heteromer
P01889; P03206;
21-119
100ACT;NA;
HLA-B*57:03 presenting the peptide ASLNLPAVSW Heteromer
I3ZN84; P35221;
21-119
100PEG;ACT;
Crystal Structure of HLA B*3508 in complex with a HCMV 8-mer peptide from the pp65 protein Heteromer
P01889; P18139;
21-119
100
Crystal structure of peptide KAGQVVTIW in complex with HLA-B5801 Heteromer
F4NC28; P02545;
21-119
100GOL;
Crystal Structure of HLA-B*37:01 in complex with NP338 influenza peptide Heteromer
P01889;
21-119
100ACT;
Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N222-230 Heteromer
P0DTC9; Q861F7;
21-119
100CD;CA;EDO;
Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs Potentiall… Heteromer
P01889; Q8URG0;
21-119
100
Crystal structure of BRLF peptide from EBV in complex with HLA-A1101. Heteromer
P04439;
21-119
100GOL;
Crystal Structure of HLA-B*44:05 in complex with NP338 influenza peptide Heteromer
P01889;
21-119
100ACT;
Crystal structure of HLA-B2709 complexed with the nona-peptide mQ Heteromer
A0A2R7Z5J3;
21-119
100GOL;
HLA-A02 carrying YLGGPDFPTI Heteromer
P04439;
21-119
10014×EDO;SO4;
Structures of HLA-B8E76C loaded with long peptides reveal novel features at the N-terminus of the g… Heteromer
Q5SS57;
21-119
100
Crystal Structure of HLA-B*2705-W60A in complex with LRN, a self-peptide Heteromer
P01889; P37268;
21-119
100
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P01889; P04585;
21-119
100EDO;
Crystal structure of HLA-B2709 complexed with the nona-peptide mA Heteromer
A0A2R7Z5J3;
21-119
100GOL;CL;
HLA-A02 carrying MVWGPDPLYV Heteromer
P04439;
21-119
10010×EDO;GOL;
Structure of a nested set of N-terminally extended MHC I-peptides provides novel insights into anti… Heteromer
P01889;
21-119
100
Crystal structure of peptide KAGQVVTI in complex with HLA-B5801 Heteromer
A0A678ZMW1; P02545;
21-119
100GOL;
Crystal Structure of HLA B*0801 in complex with ELN_YYM, ELNRKMIYM Heteromer
P01889; Q9YRL8;
21-119
100EDO;
The structure of HLA-A*3003/NP44 Heteromer
P04439; Q9Q0U8;
21-119
100
CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX Heteromer
P04439; P43358;
21-119
1001PG;
Crystal structure of HLA B*18:01 in complex with YERMCNIL, an 8-mer epitope from Influenza A Heteromer
Q91UL1; S6AU73;
21-119
100EDO;MG;K;SO4;NO3;
Crystal structure of the disulfide engineered HLA-A0201 molecule in complex with one GL dipeptide i… Heteromer
F6IQS1;
21-119
100NA;GLY;LEU;GOL;
Structure of HLA-A2:01 with peptide MM96 Heteromer
A0A140T913; P01116;
21-119
100GOL;SO4;NA;
Crystal structure of hla-b*2705 complexed with the glucagon receptor (gr) peptide (residues 412-420) Heteromer
P01889; P47871;
21-119
100GOL;NA;
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide A7H v… Heteromer
P04439; Q6SW59;
21-119
100
Crystal Structure of HLA-B8 in complex with ELR, an Influenza A virus peptide Heteromer
P01889;
21-119
100
A structural basis for immunodominant human T-cell receptor recognition. Heteromer
P01848; P01850; P04439;
21-119
100
Crystal structure of peptide VSFIEFVI in complex with HLA-B5801 Heteromer
A0A678ZMW1; P03203;
21-119
100GOL;
HLA-B*1801 in complex with a self-peptide, DELEIKAY Heteromer
P01889;
21-119
100ACT;
Crystal structure of HLA-B*27:05 complexed with the self-peptide pVIPR Heteromer
P01889; P32241;
21-119
100GOL;
Crystal Structure of HLA-B*2705 in complex with LRN, a self-peptide Heteromer
A0A583ZBQ2; P37268;
21-119
100
Crystal structure of HLA B*18:01 in complex with TEVETYVL, an 8-mer epitope from Influenza A Heteromer
Q2PIM0; S6AU73;
21-119
100EDO;MG;
Crystal structure of peptide VSFIEFVGW in complex with HLA-B5801 Heteromer
F4NC28; P03203;
21-119
100GOL;
Crystal Structure of HLA-B*35:01 in complex with IPFAMQMAY, an 9-mer epitope from SARS-CoV-2 spike … Heteromer
P0DTC2; Q546I9;
21-119
100PO4;NA;
Crystal structure of HLA-A*1101 with sars nucleocapsid peptide Heteromer
P04439; P59595;
21-119
100SO4;GOL;
Crystal Structure of HLA-B*57:01 with a modified HIV peptide RKV-Kyn Heteromer
P01889; P04578;
21-119
100ACT;
Crystal structure of HLA-B*44:05 (T73C) with 6mer EEFGRC and dipeptide GL Heteromer
D5H3J5;
21-119
100EDO;GOL;
Crystal Structure of HLA-B*2703-P47G in complex with LRN, a self-peptide Heteromer
P01889; P37268;
21-119
100
HLA-A02 carrying RQWGPDPAAV Heteromer
P04439;
21-119
10018×EDO;GOL;MES;SO4;ACY;
CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (V… Heteromer
P01889; P32241;
21-119
100GOL;MN;
Conformational Restraints and Flexibility of 14-Meric Peptides in Complex with HLA-B*3501 Heteromer
P01889;
21-119
100
Structure of a nested set of N-terminally extended MHC I-peptides provides novel insights into anti… Heteromer
P01889;
21-119
100
Structures of HLA-B8E76C loaded with long peptides reveal novel features at the N-terminus of the g… Heteromer
Q5SS57;
21-119
100
HLA-A02 carrying YLGGPDFPTI Heteromer
P04439;
21-119
100BR; 17×EDO;GOL; 11×PG4;
HLA-B*18:01 in complex with Epstein-Barr virus BZLF1-derived peptide (residues 173-180) Heteromer
P01889; Q3KSS8;
21-119
100ACT;
Structure of HLA-A2:01 with peptide MM92 Heteromer
A0A140T913; P01116;
21-119
100GOL;NA;SO4;
Crystal Structure of HLA-A*11:01 in complex with NSASFSTFK, an 9-mer epitope from SARS-CoV-2 spike … Heteromer
P0DTC2; U5YJK1;
21-119
100GOL;SO4;NA;CL;CA;
Structure of HLA-A2:01 with the 12-mer peptide F12K Heteromer
B6KDY1; P04439;
21-119
100GOL;
Crystal structure of HLA-B*07:02 in complex with an NY-ESO-1 peptide Heteromer
P01889; P78358;
21-119
100
crystal structure of HLA B*3508LPEP151A, HLA mutant Ala151 Heteromer
C5MK56; P03206;
21-119
100
A COVID-19 T-cell response detection method based on a newly identified human CD8+ T cell epitope f… Heteromer
A0A6M6CC39; P0DTC9;
21-119
100
Crystal Structure of HLA-B5703 and HIV-1 peptide Heteromer
P01889; Q1KW74;
21-119
100
The role of T cell receptor alpha genes in directing human MHC restriction Heteromer
O19626; P03211;
21-119
100
Crystal structure of HLA-B*3508 presenting 13-mer EBV antigen LPEPLPQGQLTAY Heteromer
P01889;
21-119
100
Engineered Human HLA_A2 MHC Class I molecule in complex with NV9 peptide Heteromer
P04439;
21-119
100GOL;CO;
Crystal structure of HLA-B*13:01 Heteromer
F4NBP7; P04601;
21-119
100
The structure of HLA-A*3001/RT313 Heteromer
P04439; P04585;
21-119
100
Crystal Structure of HLA A*2402 in complex with YFSPIRVTF, an 9-mer influenza epitope Heteromer
A0A5H2UYS3; C0RVT5;
21-119
100MG;
Crystal Structure of HLA-B*2703 in complex with KK10, an HIV peptide Heteromer
P01889; P04585;
21-119
100MG;
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH SYNTHETIC PHOSPHONO-MLL PEPTIDE ANALOG Heteromer
P01889; Q03164;
21-119
100GOL;NA;
Crystal Structure of HLA-B*2703 in complex with LRN, a self-peptide Heteromer
P01889; P37268;
21-119
100
HAL-A02 carrying RQFGPDFPTI Heteromer
P04439;
21-119
10010×EDO;GOL;SO4;CA;
HLA Class I antigen Heteromer
P04439; P40967;
21-119
10018×EDO; 10×GOL;SO4;
Crystal structure of engineered TCR (756) complexed to HLA-A*02:01 presenting MAGE-A10 9-mer peptide Heteromer
A0A140T913; P43363;
21-119
100GOL;
Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A27L su… Heteromer
P04439; Q16655;
21-119
100GOL;FMT;NA;
HLA A02 presenting SLYNTIATL Heteromer
P04439; P04591;
21-119
100EDO;GOL;
CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTE… Heteromer
P01889; P13285;
21-119
100GOL;
Structure of HLA-A2:01 with peptide MM90 Heteromer
A0A140T913; P01116;
21-119
100GOL;NA;
crystal structure of HLA B*3508 LPEP-P9Ala, peptide mutant P9-ala Heteromer
P01889;
21-119
100
Crystal Structure of HLA-B*37:01 in complex with NP338-V6L influenza peptide Heteromer
P01889;
21-119
100
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH SYNTHETIC SULFO-MLL PEPTIDE ANALOG Heteromer
P01889; Q03164;
21-119
100GOL;
Porcine (Sus scrofa) Major Histocompatibility Complex, class I, with human beta2 micro globulin, pr… Heteromer
B1PJV3; P03466;
21-119
100SO4;
Crystal structure of a HLA-B*35:01-NP8 epitope from 2005 H1N1 influenza strain Heteromer
F4NBT2;
21-119
100ACT;
Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N138-146 Heteromer
P0DTC9; Q861F7;
21-119
100CD;ACT;
Structure of HLA-A2:01 with peptide MM91 Heteromer
A0A140T913; P01116;
21-119
100GOL;NA;
Crystal Structure of HLA-B*57:01 with an HIV peptide RKV Heteromer
P01889; P04578; P61771;
21-119
100
Crystal Structure of HLA-B8 in complex with QIK, a CMV peptide Heteromer
P01889;
21-119
100
Phosphorylation modification of MHC I polypeptide Heteromer
O78189; P18583;
21-119
100
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P01889; P04585;
21-119
10011×EDO;GOL;
Structure of a nested set of N-terminally extended MHC I-peptides provides novel insights into anti… Heteromer
P01889;
21-119
100
Structure of a nested set of N-terminally extended MHC I-peptides provide novel insights into antig… Heteromer
P01889;
21-119
100
Crystal structure of HLA B*18:01 in complex with EEIEITTHF, an 9-mer epitope from Influenza A Heteromer
Q2VNC5; S6AU73;
21-119
100PEG;EDO;
Crystal Structure of HLA-B*4403 presenting 10mer EBV antigen Heteromer
P01889; P03204;
21-119
100ACT;GOL;
Crystal Structure of MHC class I HLA-A2 molecule complexed with Human Prostaglandin Transporter dec… Heteromer
P04439; Q92959;
21-119
100
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PHOSPHOPEPTIDE AND BOUND GLYCEROL Heteromer
P01889; Q03164;
21-119
100GOL;
Crystal Structure of HLA B*0801 in complex with ELR_MYM, ELRRKMMYM Heteromer
P01889; P03169;
21-119
100ACT;
HLA-B*57:01-RVAQLENVYI in complex with abacavir Heteromer
P01889; P62318;
21-119
1001KX;SO4;
Crystal structure of the binary complex between HLA-A2 and HCMV NLV peptide Heteromer
P04439; P06725;
21-119
100
Crystal Structure of HLA B*4402 in complex with HLA DPA*0201 peptide Heteromer
P01889; Q95HB9;
21-119
100
Crystal structure of HLA-B*5301 complex with an HIV-1 Gag-derived epitope QW9 Heteromer
P04585; S6BVK3;
21-119
100GOL;
Crystal structure of B*27:04 complex bound to the pVIPR peptide Heteromer
P01889; P32241;
21-119
100GOL;CL;
Crystal Structure of PKD2 Phosphopeptide Bound to Human Class I MHC HLA-A2 Heteromer
P04439; Q9BZL6;
21-119
100EDO;
Crystal structure of HLA-b46 at 1.6 angstrom resolution Heteromer
P01889; P17763;
21-119
100NA;
Crystal Structure of HLA B2705-KK10-L6M Heteromer
P01889; P03366;
21-119
100TRS;
Crystal Structure of HLA B2705-KK10 Heteromer
P01889; P03366;
21-119
100GOL;
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P03485; P04439;
21-119
100
Crystal structure of the HLA-B8-A66-FLR, mutant A66 of the HLA B8 Heteromer
P01889; Q3KST2;
21-119
100NA;
Crystal structure of bat (Pteropus Alecto) MHC class I Ptal-N*01:01 in complex with Hendra virus-de… Heteromer
A0A125R585; O55778;
21-119
100
Crystal Structure of HLA-B7 in complex with TPR, a CMV peptide Heteromer
P01889;
21-119
97.98IOD;NA;CL;PEG;ZN;
Crystal structure of HLA-B*3501 presenting 13-mer EBV antigen LPEPLPQGQLTAY Heteromer
P01889;
21-119
100
Human Class I MHC HLA-A2 in complex with the HuD (G2L) peptide variant Heteromer
P04439;
21-119
100GOL;
Crystal Structure of HLA B*4402 in complex with EEYLKAWTF, a mimotope Heteromer
P01889;
21-119
100
HLA-A*1101 in complex with HBV peptide homologue Heteromer
P04439;
21-119
100SO4;
T cell cross-reactivity and conformational changes during TCR engagement. Heteromer
P04439;
21-119
100
T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT Heteromer
P04439;
21-119
100
HLA-B*57:03 presenting the peptide LSSPVTKSF Heteromer
I3ZN84;
21-119
100ACT;
The structure of HLA-A*3003/MTB Heteromer
P04439; P9WNK3;
21-119
100
Crystal structure of the disulfide engineered HLA-A0201 molecule in complex with one GM dipeptide i… Heteromer
F6IQS1;
21-119
100EDO;GLY;MET;CL;
HCMV US11 peptide binding to HLA-A*02:01 Heteromer
P09727; Q53Z42;
21-119
100GOL;CD;PGE;
Crystal structure of HLA-B*5701 complex with an HIV-1 Gag-derived epitope QW9 S3T variant Heteromer
O91080; U6BR87;
21-119
98.99GOL;
Crystal Structure of HLA-A68 presenting a C-terminally extended peptide Heteromer
P04439; P30279;
21-119
100EDO;NI;CD;CO;
Crystal Structure of HLA-B7 in complex with RPP, an EBV peptide Heteromer
P01889; P12977;
21-119
97.98
HLA-A2.1 KVAEIVHFL Heteromer
E0YFW1; P04439;
21-119
100
SARS-CoV-2 Spike-derived peptide S417-425 K417T mutant (TIADYNYKL) presented by HLA-A*02:01 Heteromer
P0DTC2; Q53Z42;
21-119
100ZN;CD;NA;
HLA-A02 carrying RQFGPDWIVA Heteromer
P04439;
21-119
10011×EDO;SO4;CA;GOL;
HLA-B*58:01 presenting LSSPVTKSW Heteromer
P01889;
21-119
100
Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs Potentiall… Heteromer
P01889; Q70A61;
21-119
100
Crystal structure of a HLA-B*35:08-HPVG-Q5 Heteromer
C5MK56; P03211;
21-119
100
Structure of HLA-A2 in complex with an altered peptide ligands based on Mart-1 variant epitope Heteromer
P04439; Q16655;
21-119
100GOL;
Ca2+ release from the endoplasmic reticulum of NY-ESO-1 specific T cells is modulated by the affini… Heteromer
P04439; P78358;
21-119
100
Crystal structure of a HLA-B*35:01-HPVG-A4 Heteromer
P01889; Q1HVF7;
21-119
100ACT;
Crystal Structure of RQA_M Phosphopeptide Bound to HUMAN Class I MHC HLA-A2 Heteromer
P04439; P33241;
21-119
100EDO;
Crystal structure of HLA B*13:01 in complex with SVLNDIFSRL, an 10-mer epitope from SARS-CoV-2 Spik… Heteromer
C5IYE8; P0DTC2;
21-119
100EDO;NA;
Crystal structure of the LCMV derived peptide GP34 in complex with the murine mhc class I H-2 Kb Heteromer
P01901; Q9QDK7;
21-119
100ACT;
Crystal structure of the disulfide engineered HLA-A0201 molecule in complex with one GM dipeptide i… Heteromer
F6IQS1;
21-119
100GLY;MET;GOL;
crystal structure of HLA B*3508 LPEP-P7Ala, peptide mutant P7-ala Heteromer
P01889;
21-119
100
Human Class I MHC HLA-A2 in complex with the HuD peptide Heteromer
P04439;
21-119
100GOL;
Structure of a nested set of N-terminally extended MHC I-peptides provide novel insights into antig… Heteromer
P01889;
21-119
100
HLA A02 presenting SLFNTIAVL Heteromer
P04439; P04591;
21-119
100EDO;GOL;SO4;
HLA-A24 in complex with HIV-1 Nef126-10(8I10F) Heteromer
P04439; P04603;
21-119
100
Crystal structure of peptide in complex with HLA-A1101. Heteromer
P04439;
21-119
100GOL;
Crystal structure of HLA-B*35:01-NP3 epitope from 1957 H2N2 influenza strain Heteromer
F4NBT2; P26072;
21-119
100NA;
Human HLA-A*0201-ALWGPDPAAA Heteromer
P01308; P04439;
21-119
100
Structure of HLA-A*02:01-FLPTPEELGLLGPPRPQVLA complex Heteromer
Q6UWB1; Q861F7;
21-119
100TRS;MG;
MHC I A02 Allele presenting YLQPRTFLL Heteromer
A0A140T913; P0DTC2;
21-119
100EDO;ACT;CA;
Human Class I MHC HLA-A2 in complex with Mart-1(27-35) nonameric peptide Heteromer
P04439; Q16655;
21-119
100GOL;NA;
HLA-A02 carrying AQWGPDPAAA Heteromer
P01308; P04439;
21-119
100
Crystal Structure of HLA-A*0201 in complex with ALQDA, a 15 mer self-peptide Heteromer
P04439;
21-119
100CL;PEG;MG;
HLA-B*57:01 presenting TSTTSVASSW Heteromer
P01889; Q14679;
21-119
100GOL;
HLA-A*24:02 bound to Neuroblastoma derived PHOX2B peptide Heteromer
A0A5H2UYS3; Q99453;
21-119
100GOL;
Crystal Structure of Human CD1b in Complex with PS Heteromer
P29016;
21-119
100NAG;NAG;CUY;NAG;EDO;CL;P50;NA;
Crystal structure of HLA-B2705 complexed with the nona-peptide mE Heteromer
A0A6B7HFJ9;
21-119
100GOL;
Crystal structure of HLA-B35 in complex with a pepetide antigen Heteromer
P01889; P04585;
21-119
100
Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the… Heteromer
P01889;
21-119
100
Crystal structure of the disulfide engineered HLA-A0201 molecule without peptide bound after NaCl w… Heteromer
F6IQS1;
21-119
100EDO;NA;CL;
crystal structure of HLA B*3508 LPEP157A, HLA mutant Ala157 Heteromer
C5MK56; P03206;
21-119
100
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0B4J279; A0A0K0K1A5; P01848; P01850; P04439; P78358;
21-119
100
Crystal Structure of HLA-B0702-RFL9 Heteromer
P01889; P12478;
21-119
100
Crystal Structure of HLA A*02:06 Bound to HBV Core 18-27 Heteromer
P0C6H2; Q5MAG5;
21-119
100
A natural selected dimorphism in HLA B*44 alters self, peptide reportoire and T cell recognition. Heteromer
P01889; Q95HB9;
21-119
100ACY;
Crystal Structure of RTY Phosphopeptide Bound to Human Class I MHC HLA-A2 Heteromer
P04439; Q8WVV4;
21-119
100NA;EDO;
Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009 H1N1 PB1 (498-5… Heteromer
P04439; Q9YXL6;
21-119
100
HLA-B*4405 complexed to the dominant self ligand EEFGRAYGF Heteromer
P01889; Q9TQB0;
21-119
100
Human Class I MHC HLA-A2 in complex with the nonameric Melan-A/MART-1(27-35) peptide having A28L su… Heteromer
P04439; Q16655;
21-119
100GOL;NA;
Structure of HLA-A2 P130 Heteromer
P04439; Q76R61;
21-119
100SO4;
Crystal Structure Of HLA-B*3501 Presenting an 11-Mer EBV Antigen EPLPQGQLTAY Heteromer
P01889; P03206;
21-119
100
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide V6G v… Heteromer
P04439; P06725;
21-119
100
Crystal structure of HLA-B*4402 in complex with the F7A mutant of a self-peptide derived from DPA*0… Heteromer
P01889; Q95HB9;
21-119
100GOL;
Crystal Structure of HLA-B7 with the HCMV pp65 peptide RPHERNGFTVL Heteromer
P01889; Q6SW59;
21-119
100NI;GOL;
Crystal Structure of HLA B*0801 in complex with HSKKKCDEL Heteromer
P01889; X2G898;
21-119
100
Human Class I MHC HLA-A2 in complex with the modified HTLV-1 TAX (Y5K-4-[3-Indolyl]-butyric acid) p… Heteromer
P04439;
21-119
100GOL;NA;FMT;
Crystal structure of HLA-G presenting KLPAQFYIL peptide Heteromer
P17693;
21-119
100CO;
Crystal structure of HLA-B*3508 presenting EBV peptide EPLPQGQLTAY at 1.7A Heteromer
P01889;
21-119
100
Human Class I MHC HLA-A2 in complex with the HuD (G2L,I9V) peptide variant Heteromer
P04439;
21-119
100GOL;
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-2 Heteromer
P04439;
21-119
100GOL;
Crystal Structure of B*4402 presenting a 10mer EBV epitope Heteromer
P01889; P03204;
21-119
100ACT;GOL;
Crystal structure of AMPD2 phosphopeptide bound to HLA-A2 Heteromer
P04439; Q01433;
21-119
100EDO;
Complex Structure of HLA-A*2402 with the Peptide from HCoV(CoV-229E) spike protein Heteromer
A0A5H2UYS3; P15423;
21-119
100
Human Leukocyte Antigen Class I A02 Carrying LLWNPGMAV Heteromer
P03314; P04439;
21-119
100EDO;EPE;PEG;SO4;
CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPST… Heteromer
P01889; P13285;
21-119
100GOL;
HLA-E*01:03 in complex with IL9 Heteromer
P13747; P9WNK3;
21-119
100GOL;SO4;
Crystal Structure of HLA B*3505 in complex with NPDIVIYQY, an 9-mer epitope from HIV-I Heteromer
A0A5H2UI55; P03366;
21-119
100PEG;TRS;BTB;
HLA-C*06:02 presenting ARTELYRSL Heteromer
P10321; Q9NY61;
21-119
100
Crystal structure of HLA-B*2709 complexed with a variant of the latent membrane protein 2 peptide (… Heteromer
P01889;
21-119
100GOL;TRS;MES;
Crystal structure of H2DB in complex with HSF2 melanoma neoantigen Heteromer
P01899; P38533;
21-119
100
Crystal Structure of HLA B*3501 in complex with NPDIVIYQY, an 9-mer epitope from HIV-I Heteromer
P03366; Q546I9;
21-119
100FLC;
Insights Into Crossreactivity in Human Allorecognition: The Structure of HLA-B35011 Presenting an E… Heteromer
O19626; P33260;
21-119
100GOL;
Crystal structure of the disulfide engineered HLA-A0201 molecule devoid of peptide (annealed) Heteromer
F6IQS1;
21-119
100EDO;NA;
Human Class I MHC HLA-A2 in complex with the decameric Melan-A/MART-1(26-35) peptide Heteromer
P04439; Q16655;
21-119
100GOL;NA;
Crystal Structure of HLA A*02:07 Bound to HBV Core 18-27 Heteromer
P0C6H2; Q861F6;
21-119
100
Crystal Structure of HLA B*3508 in complex with a HCMV 12-mer peptide from the pp65 protein Heteromer
P01889; P18139;
21-119
100
Crystal structure of a HLA-B*35:08-HPVG-D5 Heteromer
C5MK56; Q3KSS4;
21-119
100ACT;
Crystal structure of a HLA-B*35:08-HPVG-A4 Heteromer
C5MK56; Q1HVF7;
21-119
100ACT;
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8;
21-119
100EDO;GOL;NA;
HLA-A*02:01 bound to Neuroblastoma Derived mutant IGFBPL1 peptide Heteromer
A0A140T913; Q8WX77;
21-119
100
KIR3DL1*086 in complex with HLA-B*57:03 presenting the AW10 peptide Heteromer
I3ZN84; I6LEK9; P35221;
21-119
100NAG;
Crystal structure of HLA-B*35:01-NP9 epitope from 2006 H1N1 influenza strain Heteromer
F4NBT2;
21-119
100
HLA-B*57:01 presenting TSTFEDVKILAF Heteromer
P01889; Q6YHU6;
21-119
100GOL;ACT;
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P01889; P69726;
21-119
10012×EDO;SO4;GOL;
Peptide-MHC complex of mouse H2-Db presenting PA224 with E4C mutation Heteromer
O89752; P01899;
21-119
100NA;ACT;
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P01889; P03407;
21-119
10012×EDO;GOL;
HLA-B*27:05 presenting an HIV-1 13mer peptide Heteromer
O78189; P04585;
21-119
100GOL;
Peptide length determines the outcome of T cell receptor/peptide-MHCI engagement Heteromer
P04439;
21-119
10018×EDO;GOL;SO4;
Human Leukocyte Antigen presenting ILGKFLHRL Heteromer
O14746; P04439;
21-119
10015×EDO;GOL;SO4;
The structure of HLA-A/L1-1 Heteromer
A0A0G2JPD3; P03101;
21-119
100
Crystal Structures of HLA-B*1501 in Complex with Peptides from Human UbcH6 and Epstein-Barr Virus E… Heteromer
P01889; P51965;
21-119
100SO4;URE;GOL;
HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide Heteromer
A0A140T913; Q8WX77;
21-119
100GOL;
Crystal Structure of ILNAMIVKI peptide bound to HLA-A2 Heteromer
P04439;
21-119
100ACT;GOL;MG;
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8;
21-119
100GOL;EDO;ACT;NA;
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide V6C v… Heteromer
P04439; P06725;
21-119
100
The High Resolution Crystal Structure of HLA-A1 Complexed with the MAGE-A1 Peptide Heteromer
P04439; P43355;
21-119
100GOL;
human CD1b in complex with endogenous phosphatidylcholine and spacer Heteromer
P29016;
21-119
100NAG;6PL;6UL;GOL;SO4;
Crystal structure of HLA-B*57:01.I80N Heteromer
P01834; P01889;
21-119
100
SARS-CoV-2 Spike-derived peptide S1185-1193 K1191N mutant (RLNEVANNL) presented by HLA-A*02:01 Heteromer
P0DTC2; Q53Z42;
21-119
100CD;ZN;NA;ACT;CL;
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PEPTIDE AND BOUND GLYCEROL Heteromer
P01889; Q03164;
21-119
100GOL;
The high resolution crystal structure of HLA-B*2709 in complex with a Cathepsin A signal sequence p… Heteromer
P01889; P10619;
21-119
100GOL;
CRYSTAL STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PHOSPHOPEPTIDE Heteromer
P01889; Q03164;
21-119
100GLC;
Crystal Structure of hla-b*2705 Complexed with the Citrullinated Vasoactive Intestinal Peptide Type… Heteromer
P01889; P32241;
21-119
100
SARS-CoV-2 Spike-derived peptide S976-984 S982A mutant (VLNDILARL) presented by HLA-A*02:01 Heteromer
P0DTC2; Q53Z42;
21-119
100ACT;EDO;CD;PEG;
Crystal structure of 10-mer peptide from EBV in complex with HLA-A1101. Heteromer
P04439; P13285;
21-119
100GOL;
Crystal structure of a HLA-B*35:01-HPVG-D5 Heteromer
P01889; Q3KSS4;
21-119
100
The Immunogenicity of a Viral Cytotoxic T Cell Epitope is controlled by its MHC-bound Conformation Heteromer
P01889; P03206;
21-119
100ACY;
Crystal structure of HLA-B*4402 in complex with the F3A mutant of a self-peptide derived from DPA*0… Heteromer
P01889; Q95HB9;
21-119
100ACT;GOL;
Structure of HLA-B*40:02 in complex with the endogenous peptide REFSKEPEL Heteromer
P01889; Q9NQS7;
21-119
100
Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2 Heteromer
P04439; P40967;
21-119
100GOL;
Crystal structure of the HLA-B8FLRGRAYVL, mutant G8V of the FLR peptide Heteromer
P01889; Q3KST2;
21-119
100
KIR3DL1 in complex with HLA-B*5701 Heteromer
P01834; P01889; P43629;
21-119
100NAG;
CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V Heteromer
P04439;
21-119
100
Crystal Structure of a citrulline peptide variant of the minor histocompatibility peptide HA-1 in c… Heteromer
P04439;
21-119
100
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1972 strain Heteromer
P01889;
21-119
100
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1934 strain Heteromer
P01889;
21-119
100
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1977 strain Heteromer
P01889;
21-119
100
Crystal structure of HLA-B*0801.N80I Heteromer
P01889;
21-119
100
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5T peptide variant Heteromer
P04439;
21-119
100
The complex between H27-14 TCR and HLA-A24 bound to HIV-1 Nef134-10(6L) peptide Heteromer
P04439; Q9WPU2;
21-119
100
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-1 Heteromer
P04439;
21-119
100GOL;
HLA-B*57:03 presenting LTVQVARVW Heteromer
P01889;
21-119
100
3H4-Fab HLA-E-VL9 co-complex Heteromer
P13747;
21-119
10010×GOL;CA;
Structure of HLA-A*24:02 in complex with peptide, LYLPVRVLI (ATG2A). Heteromer
A0A5H2UYS3; Q2TAZ0;
21-119
100EDO;SO4;
Structure of B*27:09/photoRL9 Heteromer
A0A2R7Z5J3; P32241;
21-119
100GOL;TRS;1PE;PGE;
Mouse MHC class I H-2Kd with a MERS-CoV-derived peptide 37-3 Heteromer
K9N5Q8; P01902;
21-119
100
Crystal structure of Modified Melanoma Antigen gp100(209-T2M) Bound to Human Class I MHC HLA-A2 Heteromer
P04439; P40967;
21-119
10013×GOL;
Structure of HLA-A68 complexed with a tumor antigen derived peptide Heteromer
P04439; P40126;
21-119
100GOL;
An Nt-acetylated peptide complexed with HLA-B*3901 Heteromer
O00571; P01889;
21-119
100
Crystal structure of a HLA-B*35:01-NP6 epitope from 1977 H1N1 influenza strain Heteromer
F4NBT2; Q09159;
21-119
100
Peptide phosphorylation modification of MHC class I molecules Heteromer
O78189; P18583;
21-119
100
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-T8A peptide variant Heteromer
P04439;
21-119
100
Structure of S8 TCR in complex with HLA-A*03:01 bound to ELFSYLIEK peptide Heteromer
P04439;
21-119
100EDO;
Crystal structure of HLA-A*11:01 in complex with KRAS G12D peptide (VVVGADGVGK) Heteromer
A0A583ZB34; P01111;
21-119
100
Crystal structure of parent TCR (728) complexed to HLA-A*02:01 presenting MAGE-A10 9-mer peptide Heteromer
P43363; Q861F7;
21-119
100GOL;
Crystal Structure of HLA-B7 in complex with SPI, an influenza peptide Heteromer
P01889;
21-119
100
CRYSTAL STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PEPTIDE Heteromer
P01889; Q03164;
21-119
100GOL;CL;NA;
Crystal structure of B*27:06 bound to the pVIPR peptide Heteromer
P01889; P32241;
21-119
100GOL;
HLA-B*57:01 presenting GSFDYSGVHLW Heteromer
P01889;
21-119
100
Crystal structure of a HLA-B*35:01-NP7 epitope from 2002 H2N1 influenza strain Heteromer
F4NBT2;
21-119
100ACT;
The structure of HLA-A/Pep14 Heteromer
A0A0G2JPD3; P0DTC2;
21-119
100
Structure of E8 TCR in complex in human MR1 bound to 5FSA Heteromer
Q95460;
21-119
10054G;EDO;
Crystal Structure of HLA B*4405 in complex with EEYLKAWTF, a mimotope Heteromer
P01889;
21-119
100
Crystal Structure of HLA-B5703 and HIV-1 peptide Heteromer
Q70AA1; Q9MYI6;
21-119
100
crystal structure of HLA B*3508LPEP-P4Ala, peptide mutant P4-ala Heteromer
C5MK56; P03206;
21-119
100
SARS-CoV-2 spike-derived peptide S1060-1068 (VVFLHVTYV) presented by HLA-A*02:01 Heteromer
A0A140T913; P0DTC2;
21-119
100CD;NA;
The high resolution crystal structure of HLA-B*2705 in complex with a Cathepsin A signal sequence p… Heteromer
P01889; P10619;
21-119
100GOL;
Crystal structure of a HLA-B*35:01-HPVG-Q5 Heteromer
C5MK56; P03211;
21-119
100
crystal structure of HLA B*3508 LPEP158G, HLA mutant Gly158 Heteromer
C5MK56; P03206;
21-119
100ACT;
Crystal Structure of HLA-B0702-RL9 Heteromer
P01889; P12478;
21-119
100
Weak TCR binding to an unstable insulin epitope drives type 1 diabetes Heteromer
P01308; P01902;
21-119
100GOL;15P;EDO;SO4;
Crystal structure of FcRn bound to UCB-84 Heteromer
P55899;
21-119
100CYS;ER7;GOL;PEG;
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-2.1 Heteromer
P04439;
21-119
100GOL;
Crystal Structure of HLA-B*15:01 in complex with spike derived peptide NQKLIANQF from SARS-CoV-2 vi… Heteromer
P0DTC2;
21-119
100ACT;PEG;
crystal structure of HLA B*3508LPEP-P5Ala , peptide mutant P5-ala Heteromer
P01889;
21-119
100
Structure of HLA-A2:01 with peptide G9L Heteromer
P04439;
21-119
100GOL;
Crystal structure of HLA-A2*0201 in complex with a decameric altered peptide ligand from the MART-1… Heteromer
P04439;
21-119
100ZN;
6218 TCR in complex with H2-Db PA 224 Heteromer
A0A075B6C4; A0A0G2LB96; K7N5M4; K7N5N2; O89752; P01899;
21-119
100NA;
Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes Heteromer
P01889; P32241;
21-119
100GOL;
Structure of HLA-A2:01 with peptide G9V Heteromer
P04439;
21-119
100GOL;
The high resolution crystal structure of HLA-B*1402 complexed with a Cathepsin A signal sequence pe… Heteromer
P10619; Q56H30;
21-119
100GOL;
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide V5M v… Heteromer
P04439; Q03463;
21-119
100
Crystal Structure of HLA A*1101 in complex with RVLVNGTFLK, an 10-mer epitope from Influenza B Heteromer
P03502; U5YJK1;
21-119
100SO4;
Structure of HLA-A2:01 with the 11-mer peptide F11V Heteromer
P04439; S7UWA0;
21-119
100GOL;
Crystal Structure of a SARS Corona Virus Derived Peptide Bound to the Human Major Histocompatibilit… Heteromer
P01889;
21-119
100PG4;EPE;
6218 TCR in complex with H2Db PA with an engineered TCR-pMHC disulfide bond Heteromer
A0A075B6C4; A0A0G2LB96; K7N5M4; K7N5N2; O89752; P01899;
21-119
100NA;
Human Leukocyte Antigen A02 presenting ILAKFLHEL Heteromer
O14746; P04439;
21-119
10010×EDO;CA;MES;SO4;GOL;
Human Class I MHC HLA-A2 in complex with the Tel1p peptide Heteromer
P04439; P38110;
21-119
100GOL;
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH DOT1L(998-1006) PHOSPHOPEPTIDE Heteromer
P01889; Q8TEK3;
21-119
100GLC;
Weak TCR binding to an unstable insulin epitope drives type 1 diabetes Heteromer
P01308; P01902;
21-119
100EDO;GOL;SO4;
HLA-B*27:05 presenting an HIV-1 8mer peptide Heteromer
O78189; P04585;
21-119
100GOL;
Crystal Structure of HLA-B*57:01-TW10-T242N complex Heteromer
P04585; U6BR87;
21-119
100PEG;ACT;
HLA-B*57:01 presenting TSMSFVPRPW Heteromer
P01889;
21-119
100
Human Class I MHC HLA-A2 in complex with the WT-1 (126-134) (R1Y) peptide variant. Heteromer
P04439; P19544;
21-119
100GOL;
Complex Structure of HLA-A*2402 with the Peptide from HCoV(CoV-2) spike protein Heteromer
A0A5H2UYS3; P0DTC2;
21-119
100
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC Reveal Native Diagonal Bin… Heteromer
P01848; P04439; P78358;
21-119
98.99GOL;MG;SO4;IPA;EPE;
Human Major Histocompatibility Complex A2 allele presenting LLLGIGILV Heteromer
O78126;
21-119
100EDO;
TCR55 in complex with HIV(Pol448-456)/HLA-B35 Heteromer
K7N5M4; P01889; P04585; Q6IRV4;
21-119
100EDO;SO4;
SARS-CoV-2 Spike-derived peptide S976-984 (VLNDILSRL) presented by HLA-A*02:01 Heteromer
P0DTC2; Q861F7;
21-119
100ACT;CD;ZN;
The role of T cell receptor alpha genes in directing human MHC restriction Heteromer
O19626; P03211;
21-119
100
HLA-B*57:01-LTTKLTNTNI in complex with abacavir Heteromer
P00403; P01889;
21-119
1001KX;
Molecular basis for tumor infiltrating TCR recognition of hotspot KRAS-G12D mutation Heteromer
C1K0Y1; P01111;
21-119
100
Crystal structure of non-phosphorylated form of PKD2 phosphopeptide bound to HLA-A2 Heteromer
P04439; Q9BZL6;
21-119
100CD;GOL;
Human leukocyte antigen B*07:02 in complex with SARS-CoV2 epitope IPRRNVATL Heteromer
P01889; P0DTD1;
21-119
100
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1406-1415 decapeptide Heteromer
P04439; Q9DIT6;
21-119
100
Human Class I MHC HLA-A2 in complex with the native nonameric Melan-A/MART-1(27-35) peptide Heteromer
P04439; Q16655;
21-119
100GOL;
HLA-B*44:03 in complex with Epstein-Barr virus BZLF1-derived peptide (residues 169-180) Heteromer
P01889; Q3KSS8;
21-119
100GOL;ACT;
Crystal structure of HLA-B*4104 in complex with a 11mer self-peptide derived from S-methyl-5-thioad… Heteromer
P01889; Q13126;
21-119
100
Human leukocyte antigen A*0201 in complex with SARS-CoV-2 epitope YLQPRTFLL Heteromer
A0A140T913; P0DTC2;
21-119
100GOL;
Crystal structure of HLA-B*3501 presenting the human cytochrome P450 derived peptide, KPIVVLHGY Heteromer
P01889; P33260;
21-119
100
Crystal structure of human CD1b in complex with synthetic antigenic diacylsulfoglycolipid SGL12 and… Heteromer
P29016;
21-119
100NAG;NAG;SO4;ACT;T8X;ULI;GOL;
1.9A crystal structure of HLA-G Heteromer
P16104; P17693;
21-119
100CO;CL;
Human Class I MHC HLA-A2 in complex with AVGSYVYSV peptide Heteromer
A0A140T913; Q15124;
21-119
100
HLA-B*57:01 presenting SSTRGISQLW Heteromer
P01889; Q96HA1;
21-119
100GOL;
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0B4J279; A0A0K0K1A5; P01848; P01850; P04439; P78358;
21-119
100
Crystal structure of an lmp2a-derived peptide bound to human class i mhc hla-a2 Heteromer
P04439; P13285;
21-119
100IOD;EDO;CL;
Crystal Structure of HLA B*3503 in complex with NPDIVIYQY, an 9-mer epitope from HIV-I Heteromer
A0A6B7FTL9; P03366;
21-119
100GOL;
HLA B8 in complex with an Epstein Barr Virus determinant Heteromer
P01889; P12977;
21-119
100CD;
Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009H1N1 PB1 (496-50… Heteromer
P04439; Q9YXL6;
21-119
100
Structure of human MAIT TCR in complex with human MR1-RL-6-Me-7-OH Heteromer
P01850; Q6P4G7; Q95460;
21-119
1001VY;GOL;
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P04439;
21-119
100
crystal structure of HLA B*3508 LPEP155A, HLA mutant Ala155 Heteromer
C5MK56;
21-119
100
A2 HLA complex with L8A heteroclitic variant of Melanoma peptide Heteromer
P04439;
21-119
10011×GOL;MES;
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1980 strain Heteromer
P01889;
21-119
100
Human Class I MHC HLA-A2 in complex with the Peptidomimetic ELA-1.1 Heteromer
P04439;
21-119
100GOL;
Crystal Structure of HLA B*4405 in complex with EEYLQAFTY a self peptide from the ABCD3 protein Heteromer
P01889;
21-119
100PEG;
Crystal Structure of HLA-A*0201 in complex with M1-G4E Heteromer
P04439;
21-119
100
DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE Heteromer
P04439;
21-119
100ALA;ARG;
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8;
21-119
100GOL;
Rational development of high-affinity T-cell receptor-like antibodies Heteromer
P04439; P78358;
21-119
100
Crystal Structure of C12C TCR-HLAB2705-KK10-L6M Heteromer
P01889; P03366;
21-119
100SO4;
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5Q peptide variant Heteromer
P04439;
21-119
100
Crystal Structure of the minor histocompatibility peptide HA-1Arg in complex with HLA-A2 Heteromer
P04439;
21-119
100
HLA-B*15:01 complexed with a synthetic peptide Heteromer
D9J307;
21-119
100ACT;GOL;EDO;NA;
HLA-B*57:01 presenting LALLTGVRW Heteromer
P01889;
21-119
100
HLA-B*2709 bound to deca-peptide s10R Heteromer
P01889;
21-119
100GOL;
Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide Heteromer
P04439;
21-119
100MES;
Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N226-234 Heteromer
P0DTC9; Q861F7;
21-119
100CD;NA;ACT;
A peptide complexed with HLA-B*3901 Heteromer
O00571; P01889;
21-119
100
Crystal Structure of ILNAMITKI peptide bound to HLA-A2 Heteromer
P04439; Q68CZ6;
21-119
100GOL;NA;
Crystal structure of HLA-B*27:05 complexed with the self-peptide pVIPR measured at 295 K Heteromer
P01889; P32241;
21-119
100
Crystal structure of HLA-B*27:05 complexed with the self-peptide pVIPR and Copper Heteromer
P01889; P32241;
21-119
100CU;GOL;
The structure of HLA-B*1501/BM58-66AF9 Heteromer
D9J307; Q71UK7;
21-119
100
A2 HLA complex with G4A heteroclitic variant of Melanoma peptide Heteromer
P04439;
21-119
100GOL;EDO;SO4;
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P01889; P04585;
21-119
100EDO;GOL;SO4;
The structure of HLA-A/14-3-D Heteromer
A0A0G2JL56; P0DTC2;
21-119
100
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCMV pp65-495-503 nonapeptide M5A v… Heteromer
P04439; Q6SW59;
21-119
100
Crystal structure of dual peptide from EBV in complex with HLA-A*11:01 Heteromer
P04439; P13285;
21-119
100GOL;
Crystal structure of HLA-B*2705 complexed with a peptide derived from the human voltage-dependent c… Heteromer
P01889; Q01668;
21-119
100GOL;
crystal structure of HLA B*3508LPEP-P6Ala, peptide mutant P6-ala Heteromer
P01889;
21-119
100
Crystal Structure of HLA A*0301 in complex with ILRGSVAHK, a 9-mer epitope from Influenza A Heteromer
P04439; P26079;
21-119
100SO4;
Ternary complex of FcRn ectodomain, FcRn binding optimised human serum albumin and the human growth… Heteromer
P02768; P55899;
21-119
100MES;CYS;JG5;
HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide Heteromer
A0A140T913; Q8WX77;
21-119
100GOL;
Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphi… Heteromer
P01889; Q70XD7;
21-119
100
Crystal structure of HLA-B*27:05 complexed with the self-peptide pVIPR and Nickel Heteromer
P01889; P32241;
21-119
100NI;GOL;
Crystal structure of a complex between the human adenovirus type 2 E3-19K protein and MHC class I m… Heteromer
P04439; P0C213; P68979;
21-119
100
Crystal Structure of the minor histocompatibility peptide HA-1His in complex with HLA-A2 Heteromer
P04439; Q92619;
21-119
100
HLA-A24 in complex with HIV-1 Nef134-10(wt) Heteromer
P04439; Q9YYU8;
21-119
100
Crystal structure of HLA-B*2709 complexed with the double citrullinated vasoactive intestinal pepti… Heteromer
P01889; P32241;
21-119
100
Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the E63Q and K66A mu… Heteromer
P04439; P14079;
21-119
10013×GOL;SCN;
Crystal Structure of KS1 TCR in complex with HLA-B*57:01-TW10 Heteromer
P04585; U6BR87;
21-119
100ACT;NA;CL;
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5V peptide variant Heteromer
P04439;
21-119
100
Crystal Structure of HLA B*4402 in complex with EEYLQAFTY a self peptide from the ABCD3 protein Heteromer
P01889;
21-119
100
Crystal structure of HLA-A*03:01 in complex with a mutant PIK3CA peptide Heteromer
P04439; P42336;
21-119
100GOL;FMT;
HLA Class I antigen Heteromer
P04439; P40967;
21-119
100EDO;GOL;
1E6 TCR in complex with HLA-A02 carrying RQFGPDWIVA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P04439;
21-119
10015×EDO;PG4;SO4;GOL;
KIR3DL1 in complex with HLA-B*57:03 presenting the peptide LSSPVTKSF Heteromer
I3ZN84; P43629;
21-119
100NAG;
A peptide complexed with HLA-B*3901 Heteromer
O00571; P01889;
21-119
100
KRAS-G12D specific TCR9a in complex with C*05-GADGVGKSL Heteromer
A2BF26;
21-119
100MG;GOL;SO4;
Mouse MHC class I H-2Kd with a MERS-CoV-derived peptide 142-5 Heteromer
K9N5Q8; P01902;
21-119
100
HLA-B*57:01 complexed to pep-V and Abacavir Heteromer
P01889;
21-119
1001KX;CL;
The Immunogenicity of a Viral Cytotoxic T Cell Epitope is controlled by its MHC-bound Conformation Heteromer
P01889; P03206;
21-119
100ACY;
Human Class I MHC HLA-A2 in complex with the WT-1 (126-134) peptide Heteromer
P04439; P19544;
21-119
100GOL;
Crystal structure of FcRn bound to UCB-303 Heteromer
P55899;
21-119
100EQY;NAG;GOL;
Crystal structure of FcRn at pH3 Heteromer
P55899;
21-119
100GOL;
Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-… Heteromer
P01889; Q98Y46;
21-119
100
Xenoreactive complex AHIII 12.2 TCR bound to p1049/HLA-A2.1 Heteromer
P01849; P04213; P04439; Q9NPA0;
21-119
100
Crystal Structure of HLA-A*0201 in complex with NA231, an influenza epitope Heteromer
P04439; Q9Q0U7;
21-119
100
Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs Potentiall… Heteromer
P01889; Q70A61;
21-119
100
Crystal Structure of HLA A*0101 in complex with NP44-S7N, an 9-mer influenza epitope Heteromer
P04439; Q07FI1;
21-119
100
The structure of HLA-A*3003/RT313 Heteromer
A0A173ADK6; P04585;
21-119
100
HLA-A24 in complex with HIV-1 Nef126-10(8T10F) Heteromer
P04439; Q77378;
21-119
100
Newly identified epitope V60 from HBV core protein complexed with HLA-A*0201 Heteromer
P04439; Q9QAC5;
21-119
100
Structure of chicken CD1-2 with bound fatty acid Heteromer
Q5GL29;
21-119
100NAG;PLM;
Crystal structure of RQA_V phosphopeptide bound to HLA-A2 Heteromer
P04439; P33241;
21-119
100EDO;NA;
MHC I A02 Allele presenting YLQLRTFLL Heteromer
A0A140T913; P0DTC2;
21-119
10012×IOD;PEG;
HIV RT derived peptide complexed to HLA-A*0301 Heteromer
P04439; Q9YV12;
21-119
100
Human Class I MHC HLA-A2(A150P) in complex with the Tel1p peptide Heteromer
P04439; P38110;
21-119
100GOL;
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance Heteromer
P04439; Q9YYH6;
21-119
100
The crystal structure of a self-peptide complexed to Abacavir and HLA-B*57:01 Heteromer
O00267; P01889;
21-119
1001KX;
HLA-A2.1 KVAELVHFL Heteromer
E0YFW1; P04439;
21-119
100
The structure of HLA-B*35:01 in complex with the peptide (RPQVPLRPMTY) Heteromer
P01889; Q9YYU8;
21-119
100
THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE Heteromer
P04439; P27797;
21-119
100
KIR3DL1*005 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide Heteromer
A0A5H2UYS3; P04601; P43629;
21-119
100NAG;
KIR3DL1 in complex with HLA-B*57:01-TW10 Heteromer
P01889; P03366; P43629;
21-119
100NAG;
Crystal structure of HLA-A*11:01 in complex with SVLNDIFSRL, an 10-mer epitope from SARS-CoV-2 Spik… Heteromer
P0DTC2; Q5S3G3;
21-119
10017×EDO;NA;PEG;CL;MG;
CD1a-phosphatidylglycerol binary structure Heteromer
P06126;
21-119
100NAG;MW9;EDO;MES;PEG;
Crystal structure of HLA-B*0801.N80I.R82L.G83R Heteromer
P01889;
21-119
100
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 2009 H1N1 swine origin… Heteromer
P01889;
21-119
100
HLA-B*15:01 complexed with a synthetic peptide Heteromer
F4NBQ1;
21-119
100EDO;NA;ACT;
Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide Heteromer
P04439;
21-119
100GOL;MES;
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1918 strain Heteromer
P01889;
21-119
100
Crystal Structure of the TK3 TCR in complex with HLA-B*3501/HPVG Heteromer
P01889; P03211;
21-119
100SO4;
Crystal structure of HLA-B*08:01 in complex with ELRSRYWAI viral peptide Heteromer
Q9Q0U8;
21-119
100EDO;PEG;
Crystal Structure of HLA B*4403 in complex with EEYLQAFTY a self peptide from the ABCD3 protein Heteromer
Q2L6G2;
21-119
100
Structure of HLA-A2 P130 Heteromer
P04439;
21-119
100PEG;
HLA-B*58:01 presenting LTVQVARVW Heteromer
P01889;
21-119
100
MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 Heteromer
P01889;
21-119
100
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P04439;
21-119
100
Structure of human MR1-Ac-6-FP in complex with human MAIT M33.64 TCR Heteromer
Q95460;
21-119
100PRO;30W;GOL;
Phosphorylation of MHC I peptide Heteromer
O78189; P18583;
21-119
100
KIR3DL1*114 in complex with HLA-B*57:03 presenting the AW10 peptide Heteromer
A0A5J6VN80; I3ZN84; P35221;
21-119
100NAG;
Crystal structure of HLA-B*5801 complex with HIV-1 gag derived peptide TW10 Heteromer
P01889; P03366;
21-119
100
Molecular basis for tumor infiltrating TCR recognition of hotspot KRAS-G12D mutation Heteromer
C1K0Y1; P01111;
21-119
100SO4;GOL;MG;
Human Class I Major Histocompatibility Complex, A02 allele, presenting IIGWMWIPV Heteromer
A0A140T913;
21-119
100EDO;GOL;SO4;NA;P4G;
HLA Class I antigen Heteromer
A0A0B4J279; A0A592; A0A5B9; P01848; P04439; P40967;
21-119
10010×EDO;GOL;SO4;
CD1a-42:2 SM binary complex Heteromer
P06126;
21-119
100FO4;MES;
1E6 TCR in complex with HLA-A02 carrying RQFGPDFPTI Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P04439;
21-119
10030×EDO;GOL;SO4;
Crystal Structure of HLA-A*0201 in complex with M1-F5L Heteromer
P04439;
21-119
100
Crystal structure of HLA-A*03:01 in complex with a wild-type PIK3CA peptide Heteromer
P04439; P42336;
21-119
100GOL;
Crystal structure of engineered TCR (796) complexed to HLA-A*02:01 presenting MAGE-A10 9-mer peptide Heteromer
P43363; Q861F7;
21-119
100GOL;CL;
HLA-B*57:01 presenting LSDSTARDVTW Heteromer
P01889;
21-119
100
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH DOT1L(998-1006) PEPTIDE Heteromer
P01889; Q8TEK3;
21-119
100GLC;NA;
Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the K66A mutation in… Heteromer
P04439; P14079;
21-119
10014×GOL;
SARS-CoV-2 Spike-derived peptide S269-277 (YLQPRTFLL) presented by HLA-A*02:01 Heteromer
P0DTC2; Q53Z42;
21-119
100
Structure of S2-198 TCR in complex with HLA-A*03:01 bound to ELFSYLIEK peptide Heteromer
P04439;
21-119
100TOE;EDO;PO4;
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX… Heteromer
P01889;
21-119
100
HLA-E*01:03 in complex with Mtb14 Heteromer
P13747; P9WQE5;
21-119
100GOL;SO4;
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P01889; P03407;
21-119
100GOL;EDO;SO4;
The crystal structure of class I Major histocompatibility complex, H-2Kd at 2.0 A resolution Heteromer
P01902;
21-119
100
SARS-CoV-2 YLQ peptide binds to HLA-A2 Heteromer
A0A140T913; P0DTC2;
21-119
100PG4;
HLA*A2402 complexed with HIV nef138 Y2F mutant 10mer epitope Heteromer
P04439; P04601;
21-119
100
Structure of chimeric HLA-A*11:01-A*02:01 bound to HIV-1 RT peptide Heteromer
P04585;
21-119
100
Crystal Structure of HLA A*1101 in complex with KTNGNAFIGK, an 10-mer epitope from Influenza B Heteromer
P04666; U5YJK1;
21-119
100
HLA-B*15:01 complexed with a synthetic peptide Heteromer
D9J307;
21-119
100GOL;EDO;ACT;NA;
Human Class I MHC HLA-A2 in complex with sorting nexin 24 (127-135) peptide KLSHQPVLL Heteromer
A0A140T913; Q9Y343;
21-119
100NO3;
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P01889; P03407;
21-119
100GOL;EDO;SO4;
6218 TCR in complex with H2-Db PA224-233 with a cysteine mutant Heteromer
A0A075B6C4; A0A0G2LB96; K7N5M4; K7N5N2; O89752; P01899;
21-119
100NA;
Crystal structure of HLA-B*5701 complex with an HIV-1 Gag-derived epitope QW9 Heteromer
P04585; U6BR87;
21-119
100MES;IPA;
Crystal structure of C25-NLV-HLA-A2 complex Heteromer
P04439; P18139;
21-119
100IMD;
Peptide modification of MHC class I molecules Heteromer
O78189; P18583;
21-119
100
Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-… Heteromer
P01889; P03466;
21-119
100
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide G4M-V… Heteromer
P04439; Q03463;
21-119
100
Crystal structure of HLA-B*4402 in complex with the R5A mutant of a self-peptide derived from DPA*0… Heteromer
P01889; Q95HB9;
21-119
100ACT;GOL;
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P04439; Q16655;
21-119
100
Crystal structure of HLA-B*2705 complexed with the double citrullinated vasoactive intestinal pepti… Heteromer
A3F718; P32241;
21-119
100
HLA-B*27:05 presenting an HIV-1 11mer peptide Heteromer
O78189; P04585;
21-119
100GOL;
STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH MLL(747-755) PHOSPHOPEPTIDE, CUBIC CRYSTAL FORM Heteromer
P01889; Q03164;
21-119
10012P;PE8;PGE;PEG;PG4;ACT;1PE;
Crystal Structure of B*4405 presenting a 10mer EBV epitope Heteromer
P01889; P03204;
21-119
100GOL;
Crystal structure of bat (Pteropus Alecto) MHC class I Ptal-N*01:01 in complex with Ebola virus-der… Heteromer
A0A125R585; O72142;
21-119
100
Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 Peptide RT468-476 Heteromer
P03366; P04439;
21-119
100MES;GOL;
HLA-E*01:03 in complex with Mtb44 Heteromer
P13747; P9WGR1;
21-119
100SO4;
CD1a binary complex with lysophosphatidylcholine Heteromer
P06126;
21-119
100MLT;42H;
KIR3DL1 in complex with HLA-B*57:01 presenting TSNLQEQIGW Heteromer
P01889; P03366; P43629;
21-119
100NAG;
MHC Class I A02 Allele presenting LLLGIGILVL, in complex with Mel5 TCR Heteromer
A0A140T913; Q10589;
21-119
100GOL;
Crystal structure of HLA-A0201 in complex with an azobenzene- containing peptide Heteromer
P04439;
21-119
100IPA;
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8;
21-119
100ACT;GOL;EDO;NA;
Crystal Structure of HLA-A*0201 in complex with M1-L3W Heteromer
P04439;
21-119
100
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MU… Heteromer
P01889;
21-119
100
Structure determination of an enhanced affinity TCR, a24b17, in complex with HLA-A*02:01 presenting… Heteromer
A0A5B8RNS7; Q16655;
21-119
100GOL;EDO;SO4;TAM;
PF6-M1-HLA-A2 Heteromer
P03485; P04439;
21-119
100
Structure of HLA-A2:01 with peptide G13E Heteromer
P04439;
21-119
100
Crystal Structure of the TK3-Gln55His TCR in complex with HLA-B*3501/HPVG Heteromer
P01889; P03211;
21-119
100SO4;
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-T8V peptide variant Heteromer
P04439;
21-119
100
Directed Evolution of Human T-cell Receptor CDR2 residues by phage display dramatically enhances af… Heteromer
P01848; P04439; P78358;
21-119
98.99NA;GOL;
THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM… Heteromer
P01889;
21-119
100
Human Class I MHC HLA-A2(A150P) in complex with the Tax peptide Heteromer
P04439;
21-119
100GOL;
HLA-B*2705 bound to nona-peptide m9 Heteromer
P01889;
21-119
100
KIR3DL1*001 in complex with HLA-B*57:03 presenting the AW10 peptide Heteromer
I3ZN84; P35221; P43629;
21-119
100NAG;
Crystal structure of PKD2 phosphopeptide bound to HLA-A2 Heteromer
P04439; Q9BZL6;
21-119
100CD;GOL;
Human Leukocyte Antigen Class I A02 Carrying LLWNGPMQV Heteromer
P03314; P04439;
21-119
100EDO;GOL;PEG;
Crystal Structure Of HLA-B*2709 Complexed With the self-Peptide TIS from EGF-response factor 1 Heteromer
P01889; P47974;
21-119
100GOL;
Complex Structure of HLA-A*2402 with the Peptide from HCoV(CoV-HKU1) spike protein Heteromer
A0A5H2UYS3; Q5MQD0;
21-119
100
A2 HLA complex with E1A heteroclitic variant of Melanoma peptide Heteromer
P04439;
21-119
100GOL;SO4;
1E6 TCR in complex with HLA-A02 carrying YQFGPDFPIA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P04439;
21-119
100SO4;EDO;
Engineered scFv 10LH bound to PHOX2B/HLA-A24:02 Heteromer
F6IR24; Q99453;
21-119
100GOL;NO3;
HLA Class I antigen Heteromer
P04439; P40967;
21-119
100GOL;EDO;SO4;
Crystal structure of human 0606T1-2 TCR bound to HLA-A*03:01 in complex with a mutant PIK3CA peptide Heteromer
P04439; P42336;
21-119
10013×GOL;
Crystal structure of the binary complex between HLA-A2 and HCMV NLV-M5S peptide variant Heteromer
P04439;
21-119
100
Crystal structure of HLA-B5801, a protective HLA allele for HIV-1 infection Heteromer
P01889; P04591;
21-119
100
Porcine (Sus scrofa) Major Histocompatibility Complex, class I, with human beta2 micro globulin, pr… Heteromer
B1PJV3; Q9Q0U8;
21-119
100EDO;
Crystal Structure of CD1a in Complex with a Sulfatide Heteromer
P06126;
21-119
100NAG;NAG;FUC;SLF;
Crystal structure of HLA-B*57:01.I80N.L82R.R83G Heteromer
P01834; P01889;
21-119
100
Crystal Structure of ILNAMIAKI peptide bound to HLA-A2 Heteromer
P04439; Q68CZ6;
21-119
100GOL;
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8;
21-119
100GOL;ACT;
Crystal structure of HLA-A2*0201 in complex with a nonameric altered peptide ligand (ALGIGILTV) fro… Heteromer
P04439;
21-119
100
Crystal structure of HLA-A1:MAGE-A1 in complex with Fab-Hyb3 Heteromer
P04439; P43355;
21-119
100GOL;
Structure of human MR1-DA-6-FP in complex with human MAIT A-F7 TCR Heteromer
Q95460;
21-119
1007WP;GOL;NA;
Crystal structure of DMF5 TCR bound to HLA-A2 presenting synthetic peptide MMWDRGLGMM Heteromer
P04439;
21-119
100
HLA-E*01:03 in complex with the Mtb44 peptide variant: Mtb44*P2-Gln. Heteromer
P13747; P9WGR1;
21-119
100SO4;
Crystal Structure of HLA A*2402 in complex with TYQWVLKNL, an 9-mer epitope from Influenza B virus Heteromer
A0A5H2UYS3; Q9QLL6;
21-119
100
Crystal Structure of HLA A*02:03 Bound to HBV Core 18-27 Heteromer
P0C6H2; Q2LC95;
21-119
100
SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLGFIAGL) presented by HLA-A*02:01 Heteromer
P0DTC2; Q53Z42;
21-119
100
Crystal structure of InhA:01 TCR in complex with HLA-E (Y84C) bound to InhA (53-61 GCG) Heteromer
P13747; P9WGR1;
21-119
100EDO;
Crystal structure of TCR in complex with HLA-A*11:01 bound to KRAS-G12V peptide (VVGAVGVGK) Heteromer
A0A583ZB34; P01116; P01849; Q5R1I3;
21-119
100
Crystal structure of the 'restriction triad' mutant of HLA B*3508, beta-2-microglobulin and EBV pep… Heteromer
P01889; P03206;
21-119
100ACY;GOL;PEG;
The structure of HLA-A/Pep16 Heteromer
A0A0G2JPD3; P0DTC2;
21-119
100
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P04439;
21-119
100
Crystal structure of a H5-specific CTL epitope variant derived from H5N1 influenza virus in complex… Heteromer
P04439; Q1WDM0;
21-119
100
HLA*A2402 complex with HIV nef138 Y2F-8mer mutant epitope Heteromer
P04439; P04601;
21-119
100
Crystal structure of HLA-A*11:01 in complex with KRAS peptide (VVGAGGVGK) Heteromer
P01116; U5YJJ6;
21-119
100
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P04439; Q16655;
21-119
100
Nonstandard peptide binding of HLA-B*5101 complexed with HIV immunodominant epitope KM1(LPPVVAKEI) Heteromer
P01889; P24740;
21-119
100
Crystal structure of HLA-B*2709 complexed with the vasoactive intestinal peptide type 1 receptor (V… Heteromer
P01889; P32241;
21-119
100GOL;MN;
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
O11822; P04439;
21-119
100
Crystal Structure Analysis of NY-ESO-1 epitope, SLLMWITQC, in complex with HLA-A2 Heteromer
P04439; P78358;
21-119
100SO4;
Crystal Structure of the human cytomegalovirus protein US2 bound to the MHC class I molecule HLA-A2… Heteromer
P04439; P09713; P14079;
21-119
100
HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOM… Heteromer
P04439; P43357;
21-119
100
Crystal Structure of HLA-A*03:01 in complex with VVRPSVASK, an 9-mer epitope from Influenza B virus Heteromer
P04439; P13884;
21-119
100SO4;
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
O11818; P04439;
21-119
100
CD1a-lipid binary complex Heteromer
P06126;
21-119
100FOF;EDO;
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MU… Heteromer
P01889;
21-119
100
CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058 Heteromer
P04439;
21-119
100
Human MHC Class I, A24 Allele presenting QLPRLFPLL, Complex with 4C6 TCR Heteromer
A0A5H2UYS3;
21-119
100BTB;SO4;EDO;
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MU… Heteromer
P01889;
21-119
100
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P04439;
21-119
100
TCR-antigen complex AS8.4-YEIH-HLA*B27 Heteromer
A3F718; P62723;
21-119
100GOL;
Structure of human MR1-HMB in complex with human MAIT A-F7 TCR Heteromer
Q95460;
21-119
100PRO;7WQ;GOL;
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P04439;
21-119
100
CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VA… Heteromer
P04439;
21-119
100
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, varian… Heteromer
P04439;
21-119
100
Crystal structures of high affinity human T-cell receptors bound to pMHC reveal native diagonal bin… Heteromer
P01848; P04439; P78358;
21-119
98.99SO4; 11×GOL;CA;MG;EPE;
Uncommon structural features of rabbit MHC class I (RLA-A1) complexed with rabbit haemorrhagic dise… Heteromer
P06140; P27410;
21-119
100
HLA B7:02 with RPIIRPATL Heteromer
P01889; P04666;
21-119
100EDO;
Newly identified epitope Mn2 from SARS-CoV M protein complexed withHLA-A*0201 Heteromer
P04439; P59596;
21-119
100
Structure of UL18, a Peptide-Binding Viral MHC Mimic, Bound to a Host Inhibitory Receptor Heteromer
P08560; P60709; Q8NHL6;
21-119
100NAG;MAN;BMA;FUC;
STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY … Heteromer
P04439; P04602;
21-119
100
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8;
21-119
100EDO;ACT;GOL;
Human Leukocyte Antigen Class I A02 Carrying LLWNGPIAV Heteromer
P03314; P04439;
21-119
100GOL;EDO;SO4;PEG;
Crystal structure of MHC-I H2-KD complexed with peptides of Mycobacterial tuberculosis (YQSGLSIVM) Heteromer
P01902; P9WQP1;
21-119
100GOL;EDO;
HHAT L75F Neoantigen Peptide KQWLVWLFL Presented by HLA-A206 Heteromer
Q5VTY9; U5YJP1;
21-119
100
HLA-B*27:05 presenting an HIV-1 6mer peptide Heteromer
O78189; P04585;
21-119
100ARG;
Crystal structure of the vaccinia derived peptide A11R in complex with the murine MHC CLASS I H-2 KB Heteromer
P01901; Q49PI7;
21-119
100
CD1a-36:2 SM binary complex Heteromer
P06126;
21-119
100WU7;EDO;NAG;
Crystal Structure Determination Of HLA A2 Complexed to Peptide GP2 with the substitution (I2L/V5L/L… Heteromer
P04439;
21-119
100
Crystal Structure of the cross-restricted T18A TCR and HLAB8101 bound to HIV-1 Gag TL9 peptide Heteromer
I3ZN85; P04585;
21-119
100
Human Major Histocompatibility Complex A24 Allele presenting QLPRLFPLL Heteromer
A0A5H2UYS3;
21-119
100EDO;PEG;SO4;
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 index peptide Heteromer
A0A075B6T6; A0A0K0K1A5; P0DTU3; P0DTU4; P13747; Q67953;
21-119
100
HLA-B*27:05 presenting an HIV-1 14mer peptide Heteromer
O78189; P04585;
21-119
100GOL;
CD1b in complex with Phophatidylinositol Heteromer
P29016;
21-119
100PII;NO3;D12;TWT;
Crystal structure of InhA:01 TCR in complex with HLA-E bound to InhA (53-61) Heteromer
P13747; P9WGR1;
21-119
100
Crystal Structure Of HLA-B*2705 Complexed With the self-Peptide TIS from EGF-response factor 1 Heteromer
P01889; P47974;
21-119
100GOL;
Human Leukocyte Antigen A02 presenting ILAKFLHTL Heteromer
O14746; P04439;
21-119
100SO4;EDO;
AS4.3-PRPF3-HLA*B27 Heteromer
A3F718; O43395;
21-119
100NAG;ASP;SO4;EDO;
Uncommon structural features of rabbit MHC class I (RLA-A1) complexed with rabbit haemorrhagic dise… Heteromer
P06140; P27410;
21-119
100
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P04439;
21-119
100
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified TAX (Y5F) peptide Heteromer
P04439;
21-119
10011×GOL;
Crystal Structure of HLA-A*2402 in complex with avian influenza A(H7N9) virus-derived peptide H7-25… Heteromer
A0A0X9JHC1; P04439;
21-119
100
HLA-A24 in complex with HIV-1 Nef134-8(2F) Heteromer
P04439; P04601;
21-119
100
Crystal structure of a H5-specific CTL epitope derived from H5N1 influenza virus in complex with HL… Heteromer
P04439; Q2F4V2;
21-119
100
SARS-CoV-2 Spike-derived peptide S489-497 (YFPLQSYGF) presented by HLA-A*29:02 Heteromer
B0UXQ0; P0DTC2;
21-119
100SO4;MG;NA;
Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-… Heteromer
P01889; P03204;
21-119
100
Crystal Structures of HLA-B*1501 in Complex with Peptides from Human UbcH6 and Epstein-Barr Virus E… Heteromer
P01889; P12977;
21-119
100PG4;URE;GOL;
Human leukocyte antigen B*07:02 in complex with SARS-CoV2 epitope SPRWYFYYL Heteromer
P01889; P59595;
21-119
100P6G;
Crystal Structure of CA5 TCR-HLA B*3505-LPEP complex Heteromer
C5MK56; P01848; P01850; Q3KSS8;
21-119
100NA;IOD;
Crystal structure of bat (Pteropus Alecto) MHC class I Ptal-N*01:01 mutant (Met52 Asp53 Leu54 delet… Heteromer
A0A125R585; O55778;
21-119
100
Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 envelope peptide env120-128 Heteromer
P04439; P04583;
21-119
100MES;GOL;
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS4b-1807-1816 decapeptide Heteromer
P04439; Q9DIT6;
21-119
100
Crystal structure of MHC CLass I HLA-A2.1 bound to Cytomegalovirus (CMV) pp65 epitope Heteromer
P04439; P06725;
21-119
100GOL;
Crystal structure of MHC CLass I HLA-A2.1 bound to a Peiodate- cleavable peptide Heteromer
P04439; P06725;
21-119
100GOL;MES;
Crystal Structure of MHC class I HLA-A2 molecule complexed with EBV bmlf1-280-288 nonapeptide T4P v… Heteromer
P04439; Q3KSU1;
21-119
100
Crystal structure of LMP2 peptide from EBV in complex with HLA-A*11:01 Heteromer
P04439; P13285;
21-119
100GOL;
Crystal structure of bat (Pteropus Alecto) MHC class I Ptal-N*01:01 in complex with H17N10 influenz… Heteromer
A0A125R585; H6QM94;
21-119
100
Human leukocyte antigen A*0201 in complex with SARS-CoV2 epitope KLWAQCVQL Heteromer
A0A140T913; P0DTD1;
21-119
100GOL;
Crystal structure of MHC-I H2-KD complexed with peptides of Mycobacterial tuberculosis (YYQSGLSIV) Heteromer
P01902; P9WQP1;
21-119
100GOL;EDO;
Crystal structure of non-phosphorylated form of RTF PHOSPHOPEPTIDE BOUND TO HLA-A2 in complex with … Heteromer
O15061; P04439; Q8NHL6;
21-119
100
KIR3DL1*005 in complex with HLA-B*57:01 Heteromer
P01834; P01889; P43629;
21-119
100NAG;
THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE … Heteromer
P04439;
21-119
100
Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative Diagonal Bind… Heteromer
P01848; P04439; P78358;
21-119
98.99SO4;PGE;7PE; 11×GOL;
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P03485; P04439;
21-119
100
HLA-C*06:02 presenting VRSRR(ABA)LRL Heteromer
P10321;
21-119
100EDO;
crystal structure of HLA B*3508 LPEP-P10Ala, peptide mutant P10-ala Heteromer
P01889;
21-119
100
Crystal Structure Analysis of NY-ESO-1 epitope analogue, SLLMWITQS, in complex with HLA-A2 Heteromer
P04439;
21-119
100SO4;
Structure of HLA-A2:01 with peptide G11N Heteromer
P04439;
21-119
100GOL;
Crystal Structure Determination of HLA-A2.1 Complexed to GP2 Peptide Variant(I2L/V5L) Heteromer
P04439;
21-119
100
Crystal Structure of HLA B*4403 in complex with EEYLKAWTF, a mimotope Heteromer
P01889;
21-119
100
Crystal structure of InhA:01 TCR in complex with HLA-E (F116C) bound to InhA (53-61 H4C) Heteromer
P13747; P9WGR1;
21-119
100EDO;
Crystal structure of MHC CLass I HLA-A2.1 bound to a photocleavable peptide Heteromer
P04439;
21-119
100GOL;MES;
MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2 Heteromer
P01889;
21-119
100
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MU… Heteromer
P01889;
21-119
100
The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… Heteromer
P01848; P04439;
21-119
100
AS4.2-YEIH-HLA*B27 Heteromer
A3F718; P62723;
21-119
100GOL;NAG;
MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FAL… Heteromer
P01889;
21-119
100
HLA peptide complex Heteromer
A0A140T913; P0DTC2;
21-119
100EDO;
NYBR1-A2-SLSKILDTV Heteromer
A0A0B4J277; A0A584; K7N5M3; K7N5M4; P04439; Q9BXX3;
21-119
100PEG;EDO;GOL;SO4;EPE;
SARS-CoV-2 RLQ peptide-specific TCR pRLQ3 binds to RLQ-HLA-A2 Heteromer
A0A140T913; P0DTC2;
21-119
100
Cross-reactive 3180 TCR recognition of HLA-B*35:01-NP8 epitope from 2005 H1N1 influenza strain Heteromer
F4NBT2;
21-119
100
Weak TCR binding to an unstable insulin epitope drives type 1 diabetes Heteromer
P01308; P01902;
21-119
100EDO;GOL;SO4;
HLA2.1 KVAELVWFL Heteromer
E0YFW1; P04439;
21-119
100
Weak TCR binding to an unstable insulin epitope drives type 1 diabetes Heteromer
P01308; P01902;
21-119
100EDO;SO4;
Crystal structure of HLA-B*4001 in complex with SARS-CoV derived peptide N216-225 GETALALLLL Heteromer
A0A499S0B6; P59595;
21-119
100
The structure of HLA-A/L1-2 Heteromer
A0A0G2JPD3; P03101;
21-119
100
Crystal Structure of HLA-C*0501 in complex with SAE Heteromer
P10321;
21-119
100
Crystal structure of high affinity TCR in complex with pHLA harbouring bacterial peptide Heteromer
P13747; P9WGR1;
21-119
100
1E6 TCR in Complex with HLA-A0e carrying RQWGPDPAAV Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P04439;
21-119
10012×EDO;GOL;SO4;
Crystal structure of MHC CLass I HLA-A2.1 bound to residual fragments of a photocleavable peptide t… Heteromer
P04439;
21-119
100GOL;
A2-MHC Complex carrying FLTGIGIITV Heteromer
P04439;
21-119
100EDO;SO4;GOL;
The complex between high-affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … Heteromer
K7N5M3; K7N5M4; P04439; Q16655;
21-119
100
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8;
21-119
100GOL;
Crystal Structure of MHC class I HLA-A2 molecule complexed with Melan-A MART1 decapeptide variant Heteromer
P04439; Q16655;
21-119
100
Crystal Structure of HLA-A*02:01 in complex with KLNDLCFTNV, an 10-mer epitope from SARS-CoV-2 Spik… Heteromer
A0A140T913; P0DTC2;
21-119
100GOL;
Single chain trimer HLA-A*02:01 (Y108C, A163C) with Wilms tumor protein peptide RMFPNAPYL Heteromer
A0A6S7XV52; P16213; P19544;
21-119
100.0
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 S3N peptide Heteromer
A0A075B6T6; A0A0K0K1A5; P0DTU3; P0DTU4; P13747; Q67953;
21-119
100
Crystal structure of affinity enhanced TCR in complex with HLA-A*11:01 bound to KRAS-G12V peptide (… Heteromer
A0A583ZB34; P01116; P01849; Q5R1I3;
21-119
100
Crystal structure of H-2Dd with C84-C139 disulfide in complex with gp120 derived peptide P18-I10 Heteromer
P01900; P04578;
21-119
100
Complex of HLA-A2, a class I MHC, with a p53 peptide Heteromer
A0A140T913; P04637;
21-119
100
AS3.1-PRPF3-HLA*B27 Heteromer
A3F718; O43395;
21-119
100GOL;NAG;
Conflicting selective forces affect CD8 T-cell receptor contact sites in an HLA-A2 immunodominant H… Heteromer
O11822; P04439;
21-119
100
Crystal structure of SYNT001, a human FcRn blocking monoclonal antibody Heteromer
P55899;
21-119
100NHE;
HIV Nef derived peptide Nef73 complexed to HLA-A*0301 Heteromer
P04439; P04601;
21-119
100
Crystal Structure of HLA A*0101 in complex with NP44, an 9-mer influenza epitope Heteromer
P03466; P04439;
21-119
100
Crystal structure of HLA-A2 in complex with LILRB1 Heteromer
P04439; P04585; Q8NHL6;
21-119
100
Recognition of peptide-MHC by a V-delta/V-beta TCR Heteromer
P04439; Q9YYU8;
21-119
100
HLA*A2402 complexed with HIV nef138 10mer epitope Heteromer
P04439; P04601;
21-119
100
SARS-CoV-2 YLQ peptide-specific TCR pYLQ7 binds to YLQ-HLA-A2 Heteromer
A0A140T913; P0DTC2;
21-119
100
Crystal structure of DMF5 TCR bound to HLA-A2 presenting synthetic peptide SMLGIGIVPV Heteromer
P04439;
21-119
100
HLA-B*15:01 complexed with a synthetic peptide Heteromer
D9J307;
21-119
100ACT;EDO;GOL;
Structure of HLA-A68 complexed with an HIV derived peptide Heteromer
P04439; Q9YXY3;
21-119
100
MAGE-A3 Reactive TCR in complex with Titin Epitope in HLA-A1 Heteromer
A0A0B4J279; A0A578; A0A5B9; P01848; P04439; Q8WZ42;
21-119
100GOL; 11×SO4;
HLA*A2402 complexed with HIV nef138 8mer epitope Heteromer
P04439; P04601;
21-119
100
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide N3S v… Heteromer
P04439; Q03463;
21-119
100
Crystal structure of TK3 TCR-HLA-B*35:08-HPVG complex Heteromer
C5MK56; P01848; P01850; P03211;
21-119
100CL;NA;
Crystal structure of HLA, B*4403, and peptide EEPTVIKKY Heteromer
P01889; Q9Y5X3;
21-119
100
Structures of HLA-A*1101 in complex with immunodominant nonamer and decamer HIV-1 epitopes clearly … Heteromer
P04439; P12499;
21-119
100
Crystal structure of HLA-B*4402 in complex with the F3A/R5A double mutant of a self-peptide derived… Heteromer
P01889; Q95HB9;
21-119
100ACT;
Human leukocyte antigen A*0201 in complex with SARS-CoV2 epitope ALWEIQQVV Heteromer
A0A140T913; P0DTD1;
21-119
100GOL;PGE;
Mouse MHC class I H-2Kd with a MERS-CoV-derived peptide 37-1 Heteromer
K9N5Q8; P01902;
21-119
100
Newly identified epitope N1 derived from SARS-CoV N protein complexed with HLA-A*2402 Heteromer
P04439; P59595;
21-119
100
Crystal structure of a high affinity Human Serum Albumin variant bound to the Neonatal Fc Receptor Heteromer
P02768; P55899;
21-119
10011×SO4;
HLA-A24 in complex with HIV-1 Nef134-8(wt) Heteromer
P04439; P04601;
21-119
100
Crystal Structure of HLA-A*2402 Complexed with a Newly Identified Peptide from 2009 H1N1 PA (649-65… Heteromer
P04439; Q9YXL3;
21-119
100
CD1a-42:1 SM binary complex Heteromer
P06126;
21-119
100WUA;EDO;
Crystal structure of human CD8aa-MR1-Ac-6-FP complex Heteromer
P01732; Q95460;
21-119
10030W;PO4;CL;
Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 Heteromer
P15813;
21-119
100NAG;NAG;NAG;SO4;AGH;CL;
Crystal Structure of C12C TCR-HA B2705-KK10 Heteromer
P01889; P03366;
21-119
100
Large CDR3a loop alteration as a function of MHC mutation Heteromer
P04213; P04439; Q9NPA0;
21-119
100
Crystal structure of HLA-G presenting KGPPAALTL peptide Heteromer
P17693;
21-119
100CO;CL;
Structure of HLA-A2:01 with peptide Y16R Heteromer
P04439;
21-119
100GOL;NA;
Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-… Heteromer
F6IQY1;
21-119
100GOL;PEG;
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P04439;
21-119
100
Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphi… Heteromer
P01889; Q70XD7;
21-119
100
The complex between H27-14 TCR and HLA-A24 bound to HIV-1 Nef134-10(wt) peptide Heteromer
P04439; Q9YYU8;
21-119
100
KIR3DL1*001 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide Heteromer
A0A5H2UYS3; P04601; P43629;
21-119
100FMT;ACT;NAG;
HLA B7:02 with HPNGYKSLSTL Heteromer
P01889; P12601;
21-119
100EDO;PEG;
Next generation monomeric IgG4 Fc Heteromer
P01861; P55899;
21-119
100NAG;
Crystal Structure of HLA-A*1101 in complex with H1-22, an influenza A(H1N1) virus epitope Heteromer
P04439; P68043;
21-119
100
Crystal structure of bat (Pteropus Alecto) MHC class I Ptal-N*01:01 in complex with Ebola virus-der… Heteromer
A0A125R585; O72142;
21-119
100
Crystal Structure of MHC class I HLA-A2 molecule complexed with HCV NS3-1073-1081 nonapeptide C6V v… Heteromer
P04439; Q03463;
21-119
100
SILv44 T cell receptor bound to HLA-A2 presenting gp100T2M peptide (IMDQVPFSV) Heteromer
A0A140T913; P40967;
21-119
100FLC;
SILv44 T cell receptor bound to HLA-A2 presenting gp100 peptide (ITDQVPFSV) Heteromer
A0A140T913; P40967;
21-119
100GOL;
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01848; P01850; P04439; Q16655;
21-119
100EPE;SO4;
Crystal structure of HLA-A1101 in complex with an azobenzene- containing peptide Heteromer
P04439;
21-119
100
Ternary complex of FcRn ectodomain, FcRn binding optimised human serum albumin and the albumin-bini… Heteromer
P02768; P55899;
21-119
100MES;JG5;BME;CYS;
MHC A02 Allele presenting MTSAIGILVP Heteromer
P04439;
21-119
100
1E6 TCR in complex with HLA-A02 carrying MVW peptide Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P04439;
21-119
100EDO;SO4;GOL;
T cell receptor-p53-HLA-A2 complex Heteromer
A0A140T913; P04637;
21-119
100
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01848; P01850; P04439;
21-119
100TAM; 11×SO4;
Crystal structure of LS10-TCR/M1-HLA-A*02 complex Heteromer
P03485; P04439;
21-119
100EDT;
Crystal structure of HLA-A*11:01 in complex with KRAS peptide (VVVGAGGVGK) Heteromer
A0A583ZB34; P01111;
21-119
100
HLA class I histocompatibility antigen Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P04439;
21-119
100SO4;
HLA-A24 in complex with modified 9mer WT1 peptide Heteromer
D9UAY1; P19544;
21-119
100NAG;GOL;
Human MHC Class I, A24 Allele presenting LWM, Complex with 4C6 TCR Heteromer
A0A5H2UYS3; P01308;
21-119
100SO4;EPE;EDO;
Next generation monomeric IgG4 Fc bound to neonatal Fc receptor Heteromer
P01861; P55899;
21-119
100NAG;
Crystal structure of HLA-B*27:09 complexed with the self-peptide pVIPR and Copper Heteromer
P01889; P32241;
21-119
100CU;
Structure of S8-9F3 TCR in complex with HLA-A*11:01 bound to ELFSYLIEK peptide Heteromer
A0A583ZB34;
21-119
100
Single chain trimer HLA-A*02:01 (H98L, Y108C) with HPV.16 E7 peptide YMLDLQPETTDL Heteromer
A0A6S7XV52; P03129; P16213;
21-119
100
Human Class I MHC HLA-A2 in complex with synthetic peptide MMWDRGLGMM Heteromer
P04439;
21-119
100
The crystal structure of LC13 TcR in complex with HLAB8-EBV peptide complex Heteromer
P01848; P01850; P01889; Q3KST2;
21-119
100
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P03485; P04439;
21-119
100
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P04439; P14079;
21-119
100
Human Leukocyte Antigen Class I A02 Carrying LLWAGPMAV Heteromer
P03314; P04439;
21-119
100NA;EDO;SO4;GOL;
HLA-A24 in complex with HIV-1 Nef134-10(6L) Heteromer
P04439; Q9WPU2;
21-119
100
CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2-MICROGLOBULIN/PEPTIDE P1049 COMPLEX Heteromer
P04439; Q9NPA0;
21-119
100
Crystal structure of TK3 TCR-HLA-B*35:01-HPVG-Q5 complex Heteromer
C5MK56; P01848; P01850; P03211;
21-119
100SO4;
Mouse MHC class I H-2Kd with a MERS-CoV-derived peptide 142-2 Heteromer
K9N5Q8; P01902;
21-119
100
Crystal Structure of HLA-B*5701, presenting the self peptide, LSSPVTKSF Heteromer
P01834; P01889;
21-119
100GOL;
The human non-classical major histocompatibility complex molecule HLA-E Heteromer
P13747; P17693;
21-119
100
Crystal Structure of SB27 TCR in complex with HLA-B*3508-13mer peptide Heteromer
P01848; P01850; P01889; P03206;
21-119
100IOD;
MHC Class I A02 Allele presenting NLSALGIFST Heteromer
A0A140T913; Q9Y6M1;
21-119
100PEG;SO4;EDO;
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P04439; P04588;
21-119
100
Crystal structure of Fab fragment of antibody DX-2507 bound to FcRn-B2M Heteromer
P55899; Q6NS95; S6BAN1;
21-119
100EDO;NHE;
COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 Heteromer
A0A0K0K1A5; A0A5B9; P01848; P04437; P04439; P14079;
21-119
100
Crystal Structure of LILRB2(LIR2/ILT4/CD85d) complexed with HLA-G Heteromer
P16104; P17693; Q8N423;
21-119
100
Crystal Structure of T10 Heteromer
Q31206;
21-119
100
Crystal structure of bat (Pteropus Alecto) MHC class I Ptal-N*01:01 in complex with MERS-CoV-derive… Heteromer
A0A125R585; K9N5Q8;
21-119
100
Crystal structure of killer cell immunoglobulin-like receptor KIR2DS2 in complex with HLA-A Heteromer
P04439; P43631; Q76ZQ3;
21-119
100
Engineered Human HLA_A2 MHC Class I molecule in complex with TCR and SV9 peptide Heteromer
A0A0B4J279; A0A0K0K1A5; K7N5M4; K7N5N2; P04439;
21-119
100GOL;ACT;
Structure of human MR1-ethylvanillin in complex with human MAIT A-F7 TCR Heteromer
Q95460;
21-119
100PRO;N36;GOL;
AH3 recognition of mutant HLA-A2 W167A Heteromer
P01849; P04439; Q9NPA0;
21-119
100
The Structural Dynamics and Energetics of an Immunodominant T-cell Receptor are Programmed by its V… Heteromer
P04439;
21-119
100
DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF TH… Heteromer
P01889;
21-119
100
The complex between C1-28 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide Heteromer
P04439; Q9YYU3;
21-119
100CO;
Structure of the H2DB-TCR ternary complex with HSF2 melanoma neoantigen Heteromer
P01899; P38533;
21-119
10013×GOL;SO4;
Crystal structure of 1406 TCR bound to HLA-A2 with HCV 1406-1415 antigen peptide Heteromer
P04439; P27958;
21-119
100.0
Crystal Structure Analysis of NY-ESO-1 epitope analogue, SLLMWITQA, in complex with HLA-A2 Heteromer
P04439;
21-119
100SO4;
Crystal structure of the T-cell receptor NYE_S1 bound to HLA A2*01-SLLMWITQV Heteromer
P04439; P78358;
21-119
100
AS4.3-RNASEH2b-HLA*B27 Heteromer
A0A2R8Y7R8; A3F718;
21-119
100GOL;NAG;SO4;
Cross-reactive 3180 TCR recognition of HLA-B*35:01-NP7 epitope from 2002 H3N2 influenza strain Heteromer
F4NBT2;
21-119
100
Killer cell immunoglobulin-like receptor 2DL3 in complex with HLA-C*07:02 Heteromer
P10321; P43628; P68431;
21-119
100
Crystal structure of HLA-B5801, a protective HLA allele for HIV-1 infection Heteromer
P01889; P04585;
21-119
100
Crystal structure of HLA molecule with an KIR receptor Heteromer
F6IQA6; P27958; P43631;
21-119
100
Single chain trimer HLA-A*02:01 (Y108C) with HPV.16 E7 peptide YMLDLQPETTDL Heteromer
A0A6S7XV52; P03129; P16213;
21-119
100.0
Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr… Heteromer
P01848; P01850; Q3KSU1; Q8WLS4;
21-119
98.9911×GOL;SO4;MES;
Single chain trimer HLA-A*02:01 (H98L, Y108C) with HPV.16 E7 peptide YMLDLQPET Heteromer
A0A6S7XV52; P03129; P16213;
21-119
100.0PO4;
HLA-E*01:03 in complex with the Mtb44 peptide variant: Mtb44*P9-Phe. Heteromer
P13747; P9WGR1;
21-119
100SO4;
TCR mimic antibody (Fab fragment) in complex with AFP/HLA-A*02 Heteromer
A0A140T913; P02771;
21-119
1001PE;FMT;GOL;PG4;PGE;EPE;
The crystal structure of H-2Db complexed with a partial peptide epitope suggests an MHC Class I ass… Heteromer
P01899; P26590;
21-119
100GOL;
HHAT Wild Type Peptide KQWLVWLLL Presented by HLA-A206 Heteromer
Q5VTY9; U5YJP1;
21-119
100
High resolution crystal structure of HLA-B*1402 in complex with the latent membrane protein 2 pepti… Heteromer
P13285; Q56H30;
21-119
100
Crystal structure of MHC CLass I HLA-A2.1 bound to a peptide representing the epitope of the H5N1 (… Heteromer
P04439; Q33CG5;
21-119
100GOL;MES;
MHC Class I A02 Allele presenting NLSALGIFST, in complex with Mel5 TCR Heteromer
A0A140T913; Q9Y6M1;
21-119
100EDO;
Gag:02 TCR in complex with HLA-E. Heteromer
A0A075B6U7; A0A0B4J268; A0A0J9YX06; B6S6I4; K7N5M4; P04435; P0DSE1; P13747;
21-119
100
The complex between high affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with … Heteromer
P04439; Q16655;
21-119
100
Crystal structure of the T-cell receptor NYE_S2 bound to HLA A2*01-SLLMWITQV Heteromer
P04439; P78358;
21-119
100
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5K-4-[3-Indo… Heteromer
P01848; P01850; P04439;
21-119
100SO4; 13×GOL;3IB;
Crystal structure of a human Valpha24(-) NKT TCR in complex with CD1d/alpha-galactosylceramide Heteromer
K7N5M3; K7N5M4; P15813;
21-119
100NAG;AGH;FUC;GOL;
Crystal Structure of HLA-A*1101 in complex with H7-22, an influenza A(H7N9) virus epitope Heteromer
P04439; Q9Q0U8;
21-119
100
HLA-B*27:05 presenting an HIV-1 7mer peptide Heteromer
O78189; P04585;
21-119
100ARG;GOL;
Crystal structure of a TCR in complex with HLA-A*11:01 bound to KRAS peptide (VVVGAGGVGK) Heteromer
A0A583ZB34; P01111;
21-119
100SO4;
Uncommon structural features of rabbit MHC class I (RLA-A1) complexed with rabbit haemorrhagic dise… Heteromer
P06140; P27410;
21-119
100
The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(27-35) nonameric pe… Heteromer
P01848; P04439; Q16655;
21-119
100
Single chain trimer HLA-A*02:01 (H98L, Y108C) with HPV.16 E7 peptide YMLDLQPETTDLYC Heteromer
A0A6S7XV52; P03129; P16213;
21-119
100.0
Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the… Heteromer
P01889; Q9UM73;
21-119
100GOL;SO4;
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P04439; P04582;
21-119
100
HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1 Heteromer
P04439;
21-119
100
SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68 Heteromer
P04439;
21-119
100
Crystal structure of HLA-C*07:02 in complex with RYR peptide Heteromer
P10321; P68431;
21-119
100ZN;
Structure of HLA-A*0201 complexed with peptide Md3-C9 derived from a clustering region of restricte… Heteromer
P59596; Q53Z42;
21-119
100
HFE (HUMAN) HEMOCHROMATOSIS PROTEIN Heteromer
Q30201;
21-119
100
Crystal structure of HLA-B*4402 in complex with the R5A/F7A double mutant of a self-peptide derived… Heteromer
P01889; Q95HB9;
21-119
100GOL;
Crystal structure of the KFJ37 TCR-NY-ESO-1-HLA-B*07:02 complex Heteromer
A0A0B4J1U6; A0A0B4J268; P01889; P78358;
21-119
100
Structure of the HLA-E-VMAPRTLIL/KK50.4 TCR complex Heteromer
P01848; P01850; P13747; P16780;
21-119
100IOD;
COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 Heteromer
A0A075B6T6; A0A0K0K1A5; A0A5B9; P01848; P04439; P14079;
21-119
97.98EMC;
Crystal Structure of the LC13 TCR in complex with HLA B*4405 bound to EEYLKAWTF a mimotope Heteromer
P01848; P01850; P01889;
21-119
100
1E6-A*0201-ALWGPDPAAA Complex, Triclinic Heteromer
P01308; P04439;
21-119
100
Crystal structure of human FcRn with a monomeric peptide inhibitor Heteromer
P55899;
21-119
100
YLQ-SG3 TCR in complex with SARS-CoV-2 Spike-derived peptide S269-277 (YLQPRTFLL) presented by HLA-… Heteromer
P0DTC2; Q53Z42;
21-119
100NA;
TCR-antigen complex AS4.2-PRPF3-HLA*B27 Heteromer
A3F718; O43395;
21-119
100GOL;NAG;SO4;
SARS-CoV-2 specific private TCR RLQ7 in complex with RLQ-T1006I-HLA-A2 Heteromer
A0A140T913; P0DTC2;
21-119
100PG4;
The complex between T36-5 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide in space group P2121… Heteromer
P04439; Q9YYU3;
21-119
100
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 L6I peptide Heteromer
A0A075B6T6; A0A0K0K1A5; P0DTU3; P0DTU4; P13747; Q67953;
21-119
100
HLA-A24 in complex with HIV-1 Nef134-10(2F) Heteromer
P04439; Q9YYU3;
21-119
100
T cell receptor-p53-HLA-A2 complex Heteromer
A0A140T913; P04637;
21-119
100
MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1 Heteromer
A0A0B4J279; A0A578; A0A5B9; P01848; P04439; P43357;
21-119
100SO4;
HLA-E*01:03 in complex with the HIV epitope, RL9HIV Heteromer
P04585; P13747;
21-119
100SO4;
Crystal Structure of the cross-restricted T18A TCR and HLAB4201 bound to HIV-1 Gag TL9 peptide Heteromer
P04585; V6E0U6;
21-119
100
Human Class I MHC HLA-A2 in complex with sorting nexin 24 (127-135) neoantigen KLSHQLVLL Heteromer
Q53Z42; Q9Y343;
21-119
100PEG;GOL;
Crystal structure of a TCR in complex with HLA-A*11:01 bound to KRAS G12D peptide (VVVGADGVGK) Heteromer
A0A583ZB34; P01111;
21-119
100SO4;
Structure of HLA-A2 in complex with D76N b2m mutant and NY-ESO1 double mutant Heteromer
P04439;
21-119
98.99CL;GOL;
CRYSTAL STRUCTURE OF HLA-A2-WT1-RMF AND FAB 11D06 Heteromer
A0A140T913; P19544;
21-119
100NA;
MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G Heteromer
P01899; P04857;
21-119
100GOL;SO4;NAG;
Crystal structure of InhA:01 TCR in complex with HLA-E (S147C) bound to InhA (53-61 H3C) Heteromer
P13747; P9WGR1;
21-119
100
Human Class I Major Histocompatibility Complex, A02 allele, presenting LLS (t-butyl)Y FGTPT Heteromer
A0A140T913;
21-119
100SO4;
Crystal structure of peptide-HLA-A24 bound to S19-2 V-delta/V-beta TCR Heteromer
P03407; P04439;
21-119
100
The complex between TCR DMF5 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) peptide Heteromer
P01848; P04439;
21-119
100
The complex between TCR A6 and human Class I MHC HLA-A2 with the bound HuD peptide Heteromer
P01848; P04439;
21-119
100GOL;SO4;
Human Leukocyte Antigen Class I A02 Carrying LLWNGPMHV Heteromer
P03314; P04439;
21-119
100PEG;SO4;GOL;
Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances af… Heteromer
P01848; P01850; P04439; P78358;
21-119
97.98
COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL AN… Heteromer
P01889; P03204;
21-119
100
Rhesus macaque MHC class I molecule Mamu-B*17-HW8 Heteromer
Q89490; Q9GJ77;
21-119
100
Human Class I Major Histocompatibility Complex, A02 allele, presenting LLGWVFAQV Heteromer
A0A140T913; P13726;
21-119
100
Crystal structure of ELS4 TCR bound to HLA-B*3501 presenting EBV peptide EPLPQGQLTAY at 1.7A Heteromer
P01848; P01850; P01889; P03206;
21-119
100
Complex of T cell Receptor with HHAT Neoantigen Peptide KQWLVWLFL Presented by HLA-A206 Heteromer
Q5VTY9; U5YJP1;
21-119
100
Crystal structure of HLA-A*11:01 in complex with SVLNDILARL, an 10-mer epitope from SARS-CoV-2 Spik… Heteromer
P0DTC2; Q5S3G3;
21-119
100PEG;EDO;CL;SO4;NA;
Structure of a MHC I-Tapasin-ERp57 complex Heteromer
O15533; P01899; P30101;
21-119
100NAG;
Crystal structure of non-phosphorylated form of RQA_V phosphopeptide bound to HLA-A2 in complex wit… Heteromer
P04439; P33241; Q8NHL6;
21-119
100EDO;
CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR Heteromer
P55899;
21-119
100BME;
The complex between TCR A6 and human Class I MHC HLA-A2 with the bound Tel1p peptide Heteromer
P04439; P38110;
21-119
100GOL;
First insight into marsupial MHC I peptide presentation: immune features of lower mammals parallele… Heteromer
Q95IT0;
21-119
100
Structure of HLA-A2:01 with peptide Y10L Heteromer
P04439;
21-119
100GOL;
Crystal Structure of the LC13 TCR in complex with HLA B*4405 bound to EEYLQAFTY a self peptide from… Heteromer
P01848; P01850; P01889;
21-119
100
Murine MHC class I H-2Db in complex with human b2-microglobulin and LCMV-derived immunodminant pept… Heteromer
P01899;
21-119
100
an affinity enhanced T cell receptor in complex with HLA-A0201 restricted HCV NS3 peptide KLVALGINAV Heteromer
P04439; P27958;
21-119
97.98
The complex between T36-5 TCR and HLA-A24 bound to HIV-1 Nef134-10(2F) peptide Heteromer
P04439; Q9YYU3;
21-119
100
CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR Heteromer
P10321;
20-118
97.98
Crystal Structure of the TK3-Gln55Ala TCR in complex with HLA-B*3501/HPVG Heteromer
P01889; P03211;
21-119
100SO4;
Preservation of peptide specificity during TCR-MHC contact dominated affinity enhancement of a mela… Heteromer
P01848; P01850; P04439;
21-119
100SO4;GOL;
AS4.3-YEIH-HLA*B27 Heteromer
A3F718; P62723;
21-119
100NAG;SO4;
Cross-reactive 3180 TCR recognition of HLA-B*35:01-NP4 epitope from 1972 influenza strain Heteromer
F4NBT2; Q08041;
21-119
100
Human Leukocyte Antigen A02 presenting ILGKFLHWL Heteromer
O14746; P04439;
21-119
100EDO;SO4;
1E6-A*0201-ALWGPDPAAA Complex, Monoclinic Heteromer
P01308; P04439;
21-119
100SO4;
Structure of chimeric HLA-A*02:01 bound to CMV peptide Heteromer
D2KZ37;
21-119
100
Single chain trimer HLA-A*02:01 (Y108A) with HPV.16 E7 peptide YMLDLQPETTDLYC Heteromer
A0A678ZGP6; P03129; P16213;
21-119
100.0
HLA-E*01:03 in complex with the Mtb44 peptide variant: Mtb44*P2-Phe. Heteromer
P13747; P9WGR1;
21-119
100ZN;SO4;
The complex between the high affinity version of A6 TCR (A6c134) and human Class I MHC HLA-A2 with … Heteromer
P04439; P0C213;
21-119
10010×GOL;
TCR-peptide specificity overrides affinity enhancing TCR-MHC interactions Heteromer
H2RG00; K7N5N2; O14746; P01850; P04439;
21-119
100GOL;EDO;
Crystal Structure of HLA-A*2402 in complex with IYFSPIRVTF, an 10-mer epitope from Influenza B virus Heteromer
A0A5H2UYS3; C0RVT5;
21-119
100MG;
868 TCR in complex with HLA A02 presenting SLYFNTIAVL Heteromer
P04439; P04591;
21-119
10013×EDO;GOL;SO4;
T4H2 T cell receptor bound to HLA-A2 presenting gp100 peptide (ITDQVPFSV) Heteromer
A0A140T913; P40967;
21-119
100
A2-MHC Complex carrying FATGIGIITV Heteromer
P04439;
21-119
100SO4;
Consequences of HLA single chain trimer mutations on peptide presentation and binding affinity Heteromer
A0A678ZGP6; P03129; P16213;
21-119
100.0
SARS-CoV-2 specific private TCR RLQ7 in complex with RLQ-HLA-A2 Heteromer
A0A140T913; P0DTC2;
21-119
100PG4;
Crystal structure of pHLA-B35 in complex with TU55 T cell receptor Heteromer
P01889; P04585;
21-119
100GOL;
Crystal Structure of HLA-A*2402 in complex with 2009 pandemic influenza A(H1N1) virus and avian inf… Heteromer
A0A0X9JHC1; P04439;
21-119
100
Plasticity of human CD8 binding to peptide-HLA-A*2402 Heteromer
P01732; P04439; Q9YYU8;
21-119
100
Structure of HLA-A68 complexed with an HIV Env derived peptide Heteromer
P04439; Q70626;
21-119
100
HLA-C*06:02 presenting ARFNDLRFV Heteromer
P10321; Q13761;
21-119
100
CD1b in complex with GM2 ganglioside Heteromer
P29016;
21-119
100GM2;D12;TWT;
Crystal Structure of SB47 TCR-HLA B*3505-LPEP complex Heteromer
C5MK56; P01848; P01850; Q3KSS8;
21-119
100NA;MG;
HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR Heteromer
P02786; Q30201;
21-119
100NAG;CA;
Crystal structure of human CD1d-lysophosphatidylcholine Heteromer
P15813;
21-119
100NAG;LSC;HEX;SO4;GOL;UND;
Crystal Structure of a Human Major Histocompatibilty complex Heteromer
P13747; Q0QI92;
21-119
100
Crystal Structure of HLA-A*2402 Complexed with a telomerase peptide Heteromer
O14746; P04439;
21-119
100SO4;GOL;
Newly identified epitope from SARS-CoV membrane protein complexed with HLA-A*0201 Heteromer
P04439; P59596;
21-119
100
The complex between TCR DMF4 and human Class I MHC HLA-A2 with the bound MART-1(26-35)(A27L) decame… Heteromer
P01848; P04439; Q16655;
21-119
100
The human non-classical major histocompatibility complex molecule HLA-E Heteromer
P13747;
21-119
100SO4;
Crystal Structure of CF34 TCR in complex with HLA-B8/FLR Heteromer
P01850; P01889;
21-119
100CD;CL;NA;
Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1 bound to its MHC lig… Heteromer
P10321; P43626;
21-119
100
Crystal structure of the first class MHC mamu and Tat-Tl8 complex Heteromer
21-119
100
Crystal structure of human class i mhc (hla-a2.1) complexed with beta 2-microglobulin and hiv-rt va… Heteromer
P04439;
21-119
100
CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A Heteromer
P01848; P04439;
21-119
100
Crystal structure of the public RA14 TCR in complex with the HCMV dominant NLV/HLA-A2 epitope Heteromer
P01848; P04439;
21-119
100SO4;CL;
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5(3,4-difluo… Heteromer
P01850; P04439;
21-119
100GOL;
CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V Heteromer
P04439;
21-119
100
Complex structure of HLA0201 with recognizing SARS-CoV-2 epitope S1 Heteromer
A0A5H2UU57; P0DTC2;
21-119
100
GY9-Mamu-A*02-hb2m Heteromer
P19505; Q30597;
21-119
100
SARS-CoV-2 RLQ peptide binds to HLA-A2 Heteromer
A0A140T913; P0DTC2;
21-119
100
The complex between TCR A6 and human Class I MHC HLA-A2 with the modified HTLV-1 TAX (Y5(4-fluoroPh… Heteromer
P01848; P01850; P04439;
21-119
100GOL;
HLA class I histocompatibility antigen Heteromer
P04439;
21-119
100EPE;SO4;EDO;
Human Leukocyte Antigen A02 presenting ILAKFLHWL, in complex with cognate T-Cell Receptor Heteromer
A0A0B4J277; A0A0K0K1A5; K7N5M3; K7N5M4; O14746; P04439;
21-119
100EDO;GOL;SO4;
Class I MHC (HLA-A*02) presenting alpha fetoprotein peptide (AFP) Heteromer
A0A140T913; P02771;
21-119
100PGE;PEG;1PE;
Crystal Structure of HLA-A*11:01-GTS3 Heteromer
P04439; Q6YMS4;
21-119
100K;
T4H2 T cell receptor bound to HLA-A2 presenting gp100T2L peptide (ILDQVPFSV) Heteromer
A0A140T913; P40967;
21-119
100GOL;
THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E Heteromer
P13747;
21-119
100SO4;
Apo FcRn Structure at pH 4.5 Heteromer
P55899;
21-119
100
Complex structure of HLA2402 with recognizing SARS-CoV-2 epitope QYIKWPWYI Heteromer
F6IR24; P0DTC2;
21-119
100
Crystal Structure of 9C2 TCR bound to CD1d Heteromer
P0CF51; P15813; Q6PJ56;
21-119
100NAG;NAG;NAG;BMA;MG;JLS;CL;
Human Class I MHC HLA-A2 bound to sorting nexin 24 (127-135) neoantigen KLSHQLVLL Heteromer
A0A140T913; Q9Y343;
21-119
100PEG;
Crystal structure of HLA-B*5701 complex with HIV-1 gag derived peptide TW10 Heteromer
P01889; P03366;
21-119
100
Large CDR3a loop alteration as a function of MHC mutation. Heteromer
P01849; P04213; P04439; Q9NPA0;
21-119
100
The complex between TCR JKF6 and human Class I MHC HLA-A2 presenting the MART-1(27-35)(A27L) peptide Heteromer
P04439; Q16655;
21-119
100
HLA-B*07:02 in complex with SARS-CoV-2 nucleocapsid peptide N105-113 Heteromer
P01889; P0DTC9;
21-119
100CL;
Crystal structure of HLA-B5801, a protective HLA allele for HIV-1 infection Heteromer
P01889; P04591;
21-119
100
868 TCR in complex with HLA A02 presenting SLYNTIATL Heteromer
P04439; P04591;
21-119
100EDO;GOL;SO4;
MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE Heteromer
P01899; P04858;
21-119
100SO4;
Crystal Structure of HLA A*2402 in complex with TYQWIIRNW, an 9-mer influenza epitope Heteromer
A0A5H2UYS3; P03428;
21-119
100CA;NA;NI;
Structure of HLA-A*02:01 in complex with NY-ESO-1 peptide and PA2.1 Fab Heteromer
A0A140T9X5;
21-119
100
T4H2 T cell receptor bound to HLA-A2 presenting gp100T2M peptide (IMDQVPFSV) Heteromer
A0A140T913; P40967;
21-119
100
Crystal Structure of HLA B*0801 in complex with HSKKKCDEL and DD31 TCR Heteromer
P01889; X2G898;
21-119
100IOD;NA;
Structure of human D462-E4 TCR in complex with human MR1-5-OP-RU Heteromer
Q95460;
21-119
1002LJ;GOL;BR;NA;CL;
Crystal structure of C3 TCR complex with QW9-bound HLA-B*5301 Heteromer
P04585; S6BVK3;
21-119
100
Rational development of high-affinity T-cell receptor-like antibodies Heteromer
P04439; P78358;
21-119
100
Human FcRn extra-cellular domain complexed with Fab fragment of Rozanolixizumab Heteromer
P55899;
21-119
100CL;NA;
CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUT… Heteromer
P04439;
21-119
100
MHC A02 Allele presenting MTSAIGILPV Heteromer
P04439;
21-119
100
Complex structure of HLA2402 with recognizing SARS-CoV-2 epitope pep4 Heteromer
D9UAY1; P0DTC2;
21-119
100
Gag:02 TCR in complex with HLA-E featuring a non-natural amino acid Heteromer
A0A075B6U7; A0A0B4J268; A0A0J9YX06; K7N5M4; P04435; P0DSE1; P13747;
21-119
100
Valpha3S1 Vbeta13S1 HLA C 0602 VRSRRCLRL Heteromer
F6IQM2;
21-119
100
MHC with 9-mer peptide Heteromer
J9UGS3;
21-119
100
868 TCR in complex with HLA A02 presenting SLYNTVATL Heteromer
P04439; P04591;
21-119
100EDO;SO4;
Crystal Structure of HLA A*1101 in complex with SALEWIKNK, an 9-mer epitope from Influenza B Heteromer
P06816; U5YJK1;
21-119
100MG;SO4;
Crystal Structure of the JM22 TCR in complex with HLA-A*0201 in complex with M1-G4E Heteromer
A0A075B6N1; A0A087WT01; A0A5B9; P01848; P04439;
21-119
100
D30 TCR in complex with HLA-A*11:01-GTS1 Heteromer
A0A087WSZ9; K7N5N2; P04439; P17763;
21-119
100
The complex between TCR a7b2 and human Class I MHC HLA-A0201-WT1 with the bound RMFPNAPYL peptide. Heteromer
P04439; P19544;
21-119
100EDO;
Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the… Heteromer
P04439; Q9UM73;
21-119
100
Human MHC Class I, A24 Allele presenting QLPRLFPLL, Complex with 4C6 TCR, monoclinic form Heteromer
A0A5H2UYS3;
21-119
100MES;EDO;SO4;
T cell response to a HIV reverse transcriptase epitope presented by the protective allele HLA-B*51:… Heteromer
K7N5M3; P01850; P01889; R4WL38;
21-119
100
UL40:01 TCR in complex with HLA-E with a non-natural amino acid Heteromer
A0A087WT03; A0A087X096; A0A0B4J200; A0A5B0; A0A5B9; P01848; P13747;
21-119
100
Nonstandard peptide binding of HLA-B*5101 complexed with HIV immunodominant epitope KM2(TAFTIPSI) Heteromer
P01889; P12499;
21-119
100
The crystal structure of human CD1d with and without alpha-Galactosylceramide Heteromer
P15813;
21-119
100AGH;
STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIG… Heteromer
P10321; P43627; P52292;
21-119
100
Germline-governed recognition of a cancer epitope by an immunodominant human T cell receptor Heteromer
P01848; P01850; Q16655; Q8WLS4;
21-119
100GOL;SO4;
THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEP… Heteromer
P04439; P12901;
21-119
100
Structure of Cowpox CPXV203 in complex with MHCI (H-2Kb) Heteromer
P01012; P01901; Q8QMP2;
21-119
100
Crystal Structure of the Murine MHC Class Ib Molecule M10.5 Heteromer
Q860W6;
21-119
100NAG;
Structural basis for ineffective T-cell responses to MHC anchor residue improved heteroclitic pepti… Heteromer
P04439; Q16655;
21-119
100EDO;
T cell receptor-p53-HLA-A2 complex Heteromer
A0A140T913; P04637;
21-119
100
Crystal structure of the T-cell receptor GVY01 bound to HLA A2*01-GVYDGREHTV Heteromer
P43358; Q53Z42;
21-119
100
Emergence of immune escape at dominant SARS-CoV-2 killer T-cell epitope Heteromer
A0A140T913; P0DTC2;
21-119
100PEG;SO4;
Crystal Structure of EM2 TCR in complex with HLA-B*37:01-NP338 Heteromer
P01889;
21-119
100
HLA-B*27:05 in complex with the pan-HLA-Ia monoclonal antibody W6/32 Heteromer
A3F718;
21-119
100
Crystal Structure of HLA B*3501-IPS in complex with a Delta-Beta TCR, clone 12 TCR Heteromer
P01889; P18139;
21-119
100
Structure of HLA-A*24:02 in complex with peptide, LYLPVRVLI Heteromer
A0A5H2UYS3; Q2TAZ0;
21-119
100
KIR3DL1*086 in complex with HLA-A*24:02 presenting the NEF peptide Heteromer
A0A411J078; I6LEK9;
21-119
100NAG;
Human FcRn complexed with human serum albumin Heteromer
P02768; P55899;
21-119
100
Crystal structure of B17.R2 TCR in complex with H2D-b-NP366 Heteromer
P01899; Q9Q0U8;
21-119
100EDO;
Structure of ESK1 in complex with HLA-A*0201/WT1 Heteromer
P04439; P19544;
21-119
100
Alpha-beta TCR Binding to Neoantigen KQWLVWLFL Presented by HLA-A206 Heteromer
Q53Z42; Q5VTY9;
21-119
100GOL;
1E6 TCR in Complex with HLA-A02 carrying AQWGPDPAAA Heteromer
A0A0B4J271; A0A0B4J2E0; A0A5B9; P01308; P01848; P04439;
21-119
100
Structure of wtMHC class I with NY-ESO1 double mutant Heteromer
P04439;
21-119
100CL;GOL;
Crystal structure of HLA-B*5201 in complexed with HIV immunodominant epitope (TAFTIPSI) Heteromer
P01889; P12499;
21-119
100
The Crystal Structure of Human CD1b with a Bound Bacterial Glycolipid Heteromer
P29016;
21-119
100GMM;
Crystal structure of human TCR Alpha Chain-TRAV12-3, Beta Chain-TRBV6-5, Antigen-presenting molecul… Heteromer
A0A0B4J271; A0A0K0K1A5; A0A5B9; P01848; P15813;
21-119
100NAG;JLS;
CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22 Heteromer
Q31615;
21-119
100
Crystal Structure of SB27 TCR in complex with the 'restriction triad' mutant HLA-B*3508-13mer Heteromer
A0A5B9; P01848; P01889; P03206;
21-119
100IOD;
Crystal structure of human FcRn with a dimeric peptide inhibitor Heteromer
P55899;
21-119
100
Crystal structure of the RL42 TCR in complex with HLA-B8-FLR Heteromer
P01848; P01889; Q3KST2;
21-119
100
Structure of HD14 TCR in complex with HLA-B7 presenting an EBV epitope Heteromer
P01889; P12977;
21-119
100PEG;EDO;
The human non-classical major histocompatibility complex molecule HLA-E Heteromer
P13747;
21-119
100SO4;
Structure of the HLA-E-VMAPRTLVL/GF4 TCR complex Heteromer
P04439; P13747;
21-119
100
Crystal structure of human 21LT2-2 TCR bound to HLA-A*03:01 in complex with a mutant PIK3CA peptide Heteromer
P04439; P42336;
21-119
100ACT;GOL;
Crystal structure of the T-cell receptor NYE_S3 bound to HLA A2*01-SLLMWITQV Heteromer
P04439; P78358;
21-119
100
Complex of T cell Receptor with HHAT Wild Type Peptide KQWLVWLLL Presented by HLA-A206 Heteromer
Q5VTY9; U5YJP1;
21-119
100
Noncanonical binding of single-chain A6 TCR variant S3-4 in complex with Tax/HLA-A2 Heteromer
A0A140T913; P14079;
21-119
100MES;
Structural and functional basis for HLA-G isoform recognition of immune checkpoint receptor LILRBs Heteromer
P17693; Q8NHL6; Q9BTM1;
21-119
100IOD;
Crystal Structure of HLA-A*11:01 with GTS1 peptide Heteromer
P04439; P17763;
21-119
100CL;
HLA class I histocompatibility antigen Heteromer
P04439;
21-119
100SO4;
SARS-CoV-2 specific T cell receptor Heteromer
P0DTC9; U5YKE0;
21-119
100
human 199.54-16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 Heteromer
A0A075B6T6; A0A0C4ZKA8; A0A5B3; K7N5N2; P04439; Q16655;
21-119
100SCN;K;CL;
Crystal structure of non-phosphorylated form of RLS PHOSPHOPEPTIDE BOUND TO HLA-A2 in complex with … Heteromer
P04439; Q8NC44; Q8NHL6;
21-119
100
Crystal structure of disulfide-linked HLA-G dimer Heteromer
P16104; P17693;
21-119
100
D30 TCR in complex with HLA-A*11:01-GTS3 Heteromer
A0A087WSZ9; K7N5N2; P04439; Q6YMS4;
21-119
100
Molecular basis for tumor infiltrating TCR recognition of hotspot KRAS-G12D mutation Heteromer
C1K0Y1; P01111;
21-119
100
The complex between public TCR TD08 and HLA-A24 bound to HIV-1 Nef138-8 peptide Heteromer
F6IQZ4; P04601;
21-119
100
The complex of TCR NYN-I and HLA-A24 bound to SARS-CoV-2 Spike448-456 peptide NYNYLYRLF Heteromer
P0DTC2; Q6IVJ7;
21-119
100
TCR peptide HLA-A2 complex Heteromer
A0A140T913; P0DTC2;
21-119
100
DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF TH… Heteromer
P01889;
21-119
100
Crystal structure of CD1d-lipid-antigen complexed with Beta-2-Microglobulin, NKT15 Alpha-Chain and … Heteromer
P01848; P15813;
21-119
100NAG;NAG;AGH;
Crystal structure of human FcRn with a peptide inhibitor at multiple sites Heteromer
P55899;
21-119
100
MHC Class I A02 Allele presenting EAAGIGILTV, in complex with Mel8 TCR Heteromer
A0A140T913; Q16655;
21-119
100EDO;
human 199.16 TCR in complex with Melan-A/MART-1 (26-35) peptide and HLA-A2 Heteromer
A0A075B6N1; P01848; P04439; Q16655;
21-119
100NA;
Crystal structure of the TAPBPR-MHC I peptide editing complex Heteromer
P01899; Q53GH5;
21-119
100
Human leukocyte antigen F (HLA-F) presents peptides and regulates immunity through interactions wit… Heteromer
P30511; Q8NHL6;
21-119
100NAG;
The complex between H25-11 TCR and HLA-A24 bound to HIV-1 Nef138-8 peptide Heteromer
F6IQZ4; P04601;
21-119
100
Crystal structure of a TCR in complex with HLA-A*11:01 bound to KRAS peptide (VVGAVGVGK) Heteromer
P01116; U5YJJ6;
21-119
100
HLA-A2 (A*02:01) bound to a peptide from the Epstein-Barr virus BRLF1 protein Heteromer
P04439; Q3KSS7;
21-119
100
Crystal structure of FcRn and beta-2-microglobulin in complex with IgG1-Fc-MST-HN (efgartigimod) Heteromer
P01857; P55899;
21-119
100NAG;NAG;
Crystal structure of the four Ig-like domains of LILRB1 complexed with HLA-G Heteromer
P04908; P17693; Q8NHL6;
21-119
100
Structure of the HLA-E-VMAPRTLIL/GF4 TCR complex Heteromer
P13747; P16780;
21-119
100
Crystal structure of HLA-A*11:01 in complex with SVLNDILSRL, an 10-mer epitope from SARS-CoV-2 Spik… Heteromer
P0DTC2; Q5S3G3;
21-119
100PEG;EDO;
Neoantigen p53R175H-specific TCR 6-11 binds to p53R175H-HLA-A2 Heteromer
P04439; P04637;
21-119
100
Crystal structure of a TCR in complex with HLA-A*11:01 bound to KRAS peptide (VVGAVGVGK) Heteromer
P01116; U5YJJ6;
21-119
100
The complex between public TCR TD08 and HLA-A24 bound to HIV-1 Nef138-8 (2F) peptide Heteromer
F6IQZ4; P04601;
21-119
100
Human CD94/NKG2A in complex with HLA-E Heteromer
P13747; P17693; P26715; Q13241;
21-119
100
Crystal Structure of HLA-A2 Bound to LIR-1, a Host and Viral MHC Receptor Heteromer
P04439; P12499; Q8NHL6;
21-119
100.0
Immune receptor Heteromer
P06334; Q9BCZ1;
21-119
100NAG;NAG;NAG;
Crystal Structure of the DM1 TCR in complex with HLA-B*4405 and decamer EBV antigen Heteromer
P01848; P01889; P03204;
21-119
100
Crystal structure of TCR C7 in complex with HCMV NLV epitope presented by HLA-A2 Heteromer
P04439; P18139;
21-119
100
Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and V… Heteromer
A0A0B4J240; K7N5M3; K7N5M4; P15813;
21-119
100.0NAG;AGH;
Structure of the antibody fragment H2 in complex with HLA-A*02:01/p53R175H Heteromer
A0A140T913; P04637;
21-119
100
Ternary complex between Neonatal Fc receptor, serum albumin and Fc Heteromer
P01857; P02768; P55899;
21-119
100NAG;
Structure of NKG2A/CD94 bound to HLA-E Heteromer
P13747; P17693; P26715; Q13241;
21-119
100
HLA-A*01:01 complex with NRAS Q61K peptide by NMR Heteromer
P01111; P04439;
21-119
100
Cryo-EM structure of echovirus 11 complexed with its uncoating receptor FcRn at pH 5.5 Heteromer
A0A0R5YS56; A0A346I7K2; E0WN77; P55899; Q2LJ73;
21-119
100
Structure of the human MHC I peptide-loading complex editing module Heteromer
O15533; P04439; P27797; P30101;
21-119
100NAG;NAG;
E30 F-particle in complex with FcRn Heteromer
A0A0F6T703; A8BJF8; P55899; Q8QWB2;
21-119
100MYR;
Structure of a fully assembled T-cell receptor engaging a tumor-associated peptide-MHC I Heteromer
P04234; P04439; P07766; P09693; P20963; P40967;
21-119
100NAG;
Cryo-EM structure of Echovirus 6 complexed with its uncoating receptor FcRn at PH 7.4 Heteromer
P55899;
21-119
100SPH;K;NA;
CryoEM structure of HLA-A2 MAGEA4 (230-239) in complex with REGN6972 Fab Heteromer
P43358; Q861F7;
21-119
100
CryoEM structure of HLA-A2 MAGEA4 (286-294) in complex with H2aM31345N Fab Heteromer
P43361; Q861F7;
21-119
100
CryoEM structure of PN45428 TCR-CD3 in complex with HLA-A2 MAGEA4 Heteromer
P04234; P07766; P09693; P20963; P43358; Q861F7;
21-119
100NAG;NAG;NAG;Y01;
CryoEM structure of HLA-A2 bound to MAGEA4 (230-239) peptide Heteromer
Q53Z42;
21-119
100
Structure of a synthetic antibody in complex with a class I MHC presenting a hapten-peptide conjuga… Heteromer
A0A3G8GE10; P01116;
21-119
100MOV;
Structure of the P1B7 antibody bound to the Sotorasib-modified KRas G12C peptide presented by the A… Heteromer
P01116; P04439;
21-119
100MOV;
Structure of a synthetic antibody in complex with a class I MHC presenting a hapten-peptide conjuga… Heteromer
P01116; P04439;
21-119
100MOV;
Cryo-EM structure of HLA-B*73:01 bound to a 9mer peptide and two Fabs Heteromer
A0A858LJX3;
21-119
100
Cryo-EM structure of echovirus 11 complexed with its uncoating receptor FcRn at pH 7.4 Heteromer
A0A0R5YS56; A0A346I7K2; E0WN77; P55899; Q2LJ73;
21-119
100
Structure of a synthetic antibody in complex with a class I MHC presenting a hapten-peptide conjuga… Heteromer
P01116; P04439;
21-119
100MOV;
CryoEM structure of PN45545 TCR-CD3 in complex with HLA-A2 MAGEA4 (230-239) Heteromer
P04234; P07766; P09693; P20963; P43358; Q861F7;
21-119
100NAG;NAG;Y01;NAG;
Structure of the human PLC editing module Heteromer
O15533; P04439; P27797; P30101;
21-119
100NAG;MAN;
Crystal structure of HA-1 minor histocompatibility antigen bound to human class I MHC HLA-A2 Heteromer
P04439; Q92619;
22-119
100
Crystal structure of HLA A2*01-AVYDGREHTV Heteromer
P43358; Q53Z42;
22-119
100EDO;
Crystal Structure of Human CD1b in Complex with PG Heteromer
P29016;
21-118
100NAG;NAG;NAG;CUY;IOD;CL;NA;EDO;D3D;
Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N316-324 Heteromer
P0DTC9; Q861F7;
22-119
100ACT;CD;NA;
Crystal Structure of HLA B*0801 in complex with ELK_IYM, ELKRKMIYM Heteromer
P01889; Q9YRL3;
22-119
100ACT;
Crystal Structure of MHC class I HLA-A2 molecule complexed with AFP137 nonapeptide Heteromer
P02771; P04439;
21-118
100
Structure of HLA-B*40:02 in complex with the phosphorylated endogenous peptide REF(p)SKEPEL Heteromer
P01889; Q9NQS7;
22-119
100EDO;
Structure of DbNA(10) peptides bound to H-2Db MHC-I Heteromer
P01899; P03468;
22-119
100EDO;PEG;PO4;
Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N159-167 Heteromer
P0DTC9; Q861F7;
22-119
100
Crystal Structure of Human CD1b in Complex with Phosphatidylethanolamine C34:1 Heteromer
P29016;
21-118
100NAG;NAG;L9Q;NI;CUY;CL;IOD;EDO;
HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide Heteromer
A0A140T913; Q8WX77;
22-119
100GOL;
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P04439; P35222;
22-119
100CD;MG;GOL;
Crystal Structure of HLA-B*15:01 in complex with spike derived peptide NQKLIANAF from OC43 virus Heteromer
22-119
100ACT;
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P04439; P35222;
22-119
100GOL;MG;CD;
Crystal structure of HLA-C05 in complex with a tumor mut10m peptide Heteromer
P01116; P10321;
21-118
100
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P04439; Q9Y4H2;
22-119
100CD;MG;GOL;
Crystal Structure of Human CD1b in Complex with POPC Heteromer
P29016;
21-118
100NAG;NAG;NAG;POV;CUY;CL;EDO;NA;IOD;
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P04439; P30305;
22-119
100CD;MG;GOL;
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P04439; P30305;
22-119
100GOL;CD;MG;
Crystal Structure of Human CD1b in Complex with Endogenous PC C40:5 Heteromer
P29016;
21-118
100NAG;NAG;IOD;3IV;3IY;EDO;NA;
HLA-C*0801 Crystal Structure Heteromer
D9J353; P10321;
21-118
100
Crystal Structure of Human CD1b in Complex with Lysosulfatide Heteromer
P29016;
21-118
100NAG;NAG;SGF;CUY;IOD;EDO;CL;
Antigen presenting molecule Heteromer
P06126;
21-118
1006F8;
Molecular basis for tumor infiltrating TCR recognition of hotspot KRAS-G12D mutation Heteromer
C1K0Y1; P01111;
21-118
100
Crystal structure of HLA-C08 in complex with a tumor mut9m peptide Heteromer
C1K0Y1; P01116;
21-118
100
Crystal structure of HLA-C08 in complex with a tumor mut10m peptide Heteromer
C1K0Y1; P01116;
21-118
100
Crystal structure of human CD1b presenting Phosphatidylinositol C34:1 Heteromer
P29016;
21-118
100NAG;NAG;EDO;CL;NA;6UL;IOD;PIE;
Crystal structure of HLA B*13:01 in complex with SVLNDILARL, an 10-mer epitope from SARS-CoV-2 Spik… Heteromer
C5IYE8; P0DTC2;
22-119
100PEG;EDO;NA;
CD1a binary complex with sphingomyelin Heteromer
P06126;
21-118
1003XU;
Phosphorylation of self-peptides alters Human Leukocyte Antigen Class I-restricted antigen presenta… Heteromer
P04439; Q9Y4H2;
22-119
100CD;CO;
Structure of human MR1-Ac-6-FP in complex with human MAIT B-B10 TCR Heteromer
Q95460;
21-118
100CL;GOL;ACT;30W;NA;
HLA-B*07:02 in complex with 229E-derived coronavirus nucleocapsid peptide N75-83 Heteromer
P01889; P15130;
21-118
100ZN;NA;CL;K;BR;
Crystal Structure of Human CD1b in Complex with Sphingomyelin C34:2 Heteromer
P29016;
21-118
100NAG;NAG;EDO;3LY;6UL;CL;IOD;NI;
KIR3DL1 in complex with HLA-B*57:01.I80T Heteromer
P01834; P01889; P43629;
22-119
100NAG;
Structure of human MR1-Ac-6-FP in complex with human MAIT B-G8 TCR Heteromer
Q95460;
21-118
100GOL;30W;NA;
Structure of human MR1-Ac-6-FP in complex with human MAIT TRBV6-1 TCR Heteromer
Q95460;
21-118
10030W;
KIR3DL1*001 in complex with HLA-A*24:02 presenting the TW9 peptide Heteromer
A0A411J078; P43629; Q809Q3;
21-118
100.0NAG;
Structure of E8 TCR in complex with human MR1 bound to 6FP Heteromer
Q95460;
21-118
100JSO;
Crystal structure of LS01-TCR/M1-HLA-A*02 complex Heteromer
P03485; P04439;
22-119
100GOL;
Structure of E8 TCR in complex in human MR1 bound to 3FSA Heteromer
Q95460;
21-118
1007ZS;
Crystal structure of non-phosphorylated form of AMPD2 phosphopeptide bound to HLA-A2 Heteromer
P04439; Q01433;
22-119
100EDO;NA;
Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N351-359 Heteromer
P0DTC9; Q861F7;
22-119
1003NI;CL;CD;
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8;
21-118
100ACT;GOL;EDO;NA;
Crystal Structure of KMD Phosphopeptide Bound to Human Class I MHC HLA-A2 Heteromer
P04439; Q86UW6;
22-119
100EDO;
Structure of human MR1-5-OP-RU in complex with human MAIT M33.64 TCR Heteromer
Q95460;
21-118
1002LJ;
Structure of human MR1-Ac-6-FP in complex with human MAIT C-A11 TCR Heteromer
Q95460;
21-118
10030W;CL;GOL;B3P;
Structure of E8 TCR in complex in human MR1 bound to 3FBA Heteromer
Q95460;
21-118
100OVV;EDO;MPO;
MA2-MART1-HLAA0201 Heteromer
A0A140T9X5; Q16655;
22-119
100GOL;
Crystal Structure of HLA-A*02:01/NY-ESO-1 (SLLMWITQV) and a target specific TRACeR-I Heteromer
A0A5B8RNS7; P78358;
21-118
100SO4;
Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17 Heteromer
P15813;
21-118
100FO4;NAG;
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8;
21-118
100ACT;EDO;
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8;
21-118
100ACT;EDO;
Structure of S2 TCR in complex with HLA-A*03:01 bound to ELFSYLIEK peptide Heteromer
P04439;
22-119
100
Human CD1c with ligands in A' and F' channel Heteromer
P29016; P29017;
21-118
100DAO;STE;GOL;PO4;
Crystal structure of the BC8B TCR-CD1b-PI complex Heteromer
P29016;
21-118
100NAG;NAG;EDO;GOL;MAN;NAG;CUY;CL;NA;
Structure of human MR1-Ac-6-FP in complex with human MAIT B-F3-C1 TCR Heteromer
Q95460;
21-118
10030W;
Structure of E8 TCR in complex in human MR1 K43A Heteromer
Q95460;
21-118
100.0
Structure of human MR1-Ac-6-FP in complex with human MAIT B-C10 TCR Heteromer
Q95460;
21-118
10030W;GOL;
KIR3DL1*015 in complex with HLA-B*57:01 Heteromer
P01834; P01889; P43629;
22-119
100NAG;
Structure of human MR1-Ac-6-FP in complex with human MAIT C-C10 TCR Heteromer
Q95460;
21-118
10030W;GOL;NA;
The molecular bases of Delta/Alpha beta T cell-mediated antigen recognition. Heteromer
P15813;
21-118
100NAG;NAG;NAG;JLS;
Single chain trimer HLA-A*24:02 (Y108C, A163C) with 8mer peptide YPPVPETF Heteromer
F6IR24; P16213; Q6NSI4;
22-119
100.0
Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-C… Heteromer
P15813;
21-118
100NAG;NAG;NAG;GOL;A1AHF;SO4;
RD-1 Mart-1 High bound to Mart-1 decameric peptide (ELA) in complex with HLA-A2 Heteromer
A0A075B6T6; A0A0K0K1A5; P04439; Q16655;
22-119
100
Structure of HLA-A2:01 with peptide Y9L Heteromer
P04439;
21-118
100GOL;
The complex between TIL 1383i TCR and human Class I MHC HLA-A2 with the bound Tyrosinase(369-377)(N… Heteromer
P04439; P14679;
21-118
100.0
KIR3DL1*114 in complex with HLA-A*24:02 presenting the NEF peptide Heteromer
A0A411J078; A0A5J6VN80;
21-118
100NAG;
COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8 Heteromer
P01732; P04439;
22-119
100
CD1a-sulfatide-gdTCR complex Heteromer
A0A0C4DH28; A0A1B0GX56; P01848; P01850; P06126;
21-118
100CIS;EDO;NAG;PEG;SO4;
Consequences of HLA single chain trimer mutations on peptide presentation and binding affinity Heteromer
A0A678ZGP6; P16213; Q6NSI4;
22-119
100
Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 Heteromer
P15813;
21-118
100NAG;NAG;NAG;AGH;PEG;CL;SO4;BGC;
Crystal structure of CD1a in complex with a synthetic mycobactin lipopeptide Heteromer
P06126;
21-118
100NAG;JH0;
CD1a ternary complex with lysophosphatidylcholine and BK6 TCR Heteromer
P01848; P01850; P06126;
21-118
100NAG;42H;
Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-C… Heteromer
P15813;
21-118
100NAG;NAG;FO4;NA;
Crystal Structure of HLA A*2402 in complex with TYQWIIRNWET, an 11-mer epitope from Influenza Heteromer
A0A5H2UYS3; P03428;
21-118
100
Ternary crystal structure of the 3C8 TCR-CD1c-monoacylglycerol complex Heteromer
P29017;
22-119
100NAG;EKG;D10;K;EDO;PEG;
The complex among DMF5(alpha-D26Y, alpha-Y50A,beta-L98W) TCR, human Class I MHC HLA-A2 and MART-1(2… Heteromer
A0A075B6T6; A0A1B0GXE1; K7N5M4; P01848; P04439; Q16655;
21-118
100
CD1a-dideoxymycobactin-gdTCR complex Heteromer
A0A0C4DH28; A0A1B0GX56; P01848; P01850; P06126;
21-118
100EDO;WGR;SO4;
Killer cell immunoglobulin-like receptor 2DL2 in complex with HLA-C*07:02 Heteromer
P10321; P43627; P68431;
21-118
100
Inhibitory immune receptor protein complex Heteromer
Q95460;
21-118
100.030W;
Stimulatory immune receptor protein complex Heteromer
A0A0C4DH27; A0JD37; Q95460;
21-118
1002LJ;
CD1a-endo-gdTCR complex Heteromer
A0A0C4DH28; A0A1B0GX56; P01848; P01850; P06126;
21-118
100PEG;SO4;
Crystal structure of GEM42 TCR-CD1b-GMM complex Heteromer
P29016;
21-118
100NAG;SO4;CL;NA;6UL;CS;70E;
CD1c in complex with phosphatidylcholine Heteromer
P29017;
21-118
100.0NAG;D12;6PL;NA;SO4;BME;EDO;MES;
TCR589 in complex with HIV(Pol448-456)/HLA-B35 Heteromer
K7N5M4; P01889; P04585; Q6IRV4;
21-118
100NAG;ZN;NAG;
Crystal structure of JDI TCR in complex with HLA-A*11:01 bound to KRAS G12D peptide (VVVGADGVGK) Heteromer
A0A583ZB34; P01111;
21-118
100
Crystal Structure of TAPBPR and H2-Dd complex Heteromer
P01900; Q9BX59;
21-118
100EDO;GOL;
G12V-TCR complex with HLA-A3 Heteromer
P01116; P04439;
21-118
100
Crystal structure of TCR PF8 in complex with flu MP(58-66) epitope presented by HLA-A2 Heteromer
K7N5M3; P03485; P04439;
22-119
100.0
TCR - CD3 complex bound to HLA Heteromer
H9BNV4; P01848; P04234; P07766; P09693; P0DTU4; P20963; P78358;
21-118
100.0NAG;NAG;CLR;
Crystal Structure of HLA-A*0201 in complex with FLNDK, a 15 mer self-peptide Heteromer
P04439;
22-118
100PEG;CL;
Structure of DbNA(11) peptides bound to H-2Db MHC-I Heteromer
P01899; P03468;
23-119
100SO4;
Crystal Structure of human CD1b in complex with C36-GMM Heteromer
P29016;
21-117
100NAG;6UL;NAG;ACT;CL;70E;NA;
Structure of human MAIT A-F7 TCR in complex with human MR1-2`OH-Ethyl-5-OP-U Heteromer
Q95460;
21-117
100GOL;OZD;NA;
HLA-B*57:01 presenting LTVQVARVW Heteromer
P01889;
21-117
100
HLA-B*58:03 presenting LTVQVARVY Heteromer
P01889;
21-117
100
Structure of human MAIT A-F7 TCR in complex with human MR1-5'OH-Pentyl-5-OP-U Heteromer
Q95460;
21-117
100OYD;
Structure of human MAIT A-F7 TCR in complex with human MR1 3'D-5-OP-RU Heteromer
Q95460;
21-117
100GOL;Q81;NA;
Structure of human MAIT A-F7 TCR in complex with human MR1-5-OP-RU Heteromer
Q95460;
21-117
100Q87;GOL;CL;NA;
Structure of human MAIT A-F7 TCR in complex with human MR1-Ribityl-less Heteromer
Q95460;
21-117
100OYG;NA;
Structure of human MAIT A-F7 TCR in complex with patient MR1-R9H-Ac-6-FP Heteromer
Q95460;
21-117
100TKG;GOL;CL;
Crystal Structure of HLA-A*68:01 in complex with NP145-156, a 12 mer influenza peptide Heteromer
P04439; Q9Q0U8;
23-119
100IOD;MG;SO4;
HLA-B*57:01 presenting LTVQVARVY Heteromer
P01889;
21-117
100
Structure of human MR1-3-F-SA in complex with human MAIT A-F7 TCR Heteromer
Q95460;
21-117
1007ZS;GOL;ACT;
Structure of human MAIT A-F7 TCR in complex with human MR1-3`OH-Propyl-5-OP-U Heteromer
Q95460;
21-117
100GOL;CL;Q7S;NA;
Structure of human MAIT A-F7 TCR in complex with patient MR1-R9H without ligand Heteromer
Q95460;
21-117
100ACT;GOL;
Structure of human MAIT A-F7 TCR in complex with human MR1-4'OH-Butyl-5-OP-U Heteromer
Q95460;
21-117
100Q7P;GOL;NA;
Structure of human MAIT A-F7 TCR in complex with human MR1-2'D-5-OP-RU Heteromer
Q95460;
21-117
100GOL;Q84;NA;
Structure of human MAIT A-F7 TCR in complex with human MR1-DB28 Heteromer
Q95460;
21-117
100GOL;P1J;ACT;
Structure of S2 TCR in complex with HLA-A*11:01 bound to ELFSYLIEK peptide Heteromer
A0A583ZB34;
22-118
100
Structure of human MR1-5-OP-RU in complex with human MAIT M33.64(Y95alphaF) TCR Heteromer
Q95460;
21-117
100GOL;2LJ;
HLA-B*57:01 presenting LSSPVTKSW Heteromer
P01889;
21-117
100
HLA-B*57:03 presenting LSSPVTKSW Heteromer
I3ZN84;
21-117
100
Structure of human MR1-5-OP-RU in complex with human MAIT TRAJ20 TCR Heteromer
Q95460;
21-117
1002LJ;GOL;NA;
Crystal structure of the KFJ5 TCR-NY-ESO-1-HLA-B*07:02 complex Heteromer
A0A0B4J268; A0A5B6; P01889; P78358;
21-117
100.0
Crystal Structure of Human CD1b in Complex with PA Heteromer
P29016;
21-117
100NAG;NAG;NAG;D21;CUY;PEG;CL;EDO;IOD;NA;
Structure of human MAIT A-F7 TCR in complex with human MR1-JYM72 Heteromer
Q95460;
21-117
100GOL;OYV;NA;
Crystal Structure of Human CD1b in Complex with Mycobacterial C85-GMM Heteromer
P29016;
21-117
100NAG;ZR2;NAG;CL;IOD;
Structure of E8 TCR in complex in human MR1 bound to 4FBA Heteromer
Q95460;
21-117
1004MA;EDO;
Structure of human MAIT A-F7 TCR in complex with human MR1-NV18.1 Heteromer
Q95460;
21-117
100N18;GOL;ACT;
Crystal structure of TCR-MR1 ternary complex and non-covalently bound 5-(2-oxopropylideneamino)-6-D… Heteromer
P01850; Q6P4G7; Q95460;
21-117
100Q87;GOL;
Complex of HLA-A2, a class I MHC, with a p53 peptide Heteromer
A0A140T913; P04637;
21-117
100
Crystal structure of BC8B TCR-CD1b-PC complex Heteromer
P29016;
21-117
100NAG;CUY;POV;CL;
Structure of E8 TCR in complex with human MR1 bound to 5-OP-RU Heteromer
Q95460;
21-117
1002LJ;EDO;
KIR3DL1*114 in complex with HLA-A*24:02 presenting the TW9 peptide Heteromer
A0A411J078; A0A5J6VN80; Q809Q3;
21-117
100NAG;
The human non-classical major histocompatibility complex molecule HLA-E Heteromer
P10321; P13747;
23-119
100
Crystal structure of TK3 TCR-HLA-B*35:08-HPVG-D5 complex Heteromer
C5MK56; P01848; P01850; Q3KSS4;
23-119
98.84
Crystal Structure of the JM22 TCR in complex with HLA-A*0201 in complex with M1-F5L Heteromer
A0A075B6N1; A0A087WT01; A0A5B9; P01848; P04439;
21-117
100
Crystal structure of human CD1d-alpha-Galactosylceramide in complex with semi-invariant NKT cell re… Heteromer
P15813;
21-117
100NAG;NAG;AGH;MG;
Structure of human MR1-5OH-DCF in complex with human MAIT A-F7 TCR Heteromer
Q95460;
21-117
100ACT;GOL;
Crystal structure of TCR-MR1 ternary complex and covalently bound 5-(2-oxopropylideneamino)-6-D-rib… Heteromer
P01850; Q6P4G7; Q95460;
21-117
1002LJ;NA;
Crystal structure of a MHC class I-peptide complex Heteromer
P04439; P60201;
22-118
100
Complex structure of HLA2402 with recognizing SARS-CoV-2 Y453F epitope NYNYLFRLF Heteromer
A0A7T3RIT5; P0DTC2;
21-117
100EDO;
Crystal structure of a complex between the Human adenovirus type 4 E3-19K protein and MHC class mol… Heteromer
P04439; P14079; Q8BEL5;
21-117
100.0
Structure of human MR1-diclofenac in complex with human MAIT A-F7 TCR Heteromer
Q95460;
21-117
100NA;ACT;GOL;DIF;
Crystal structure of PG90 TCR-CD1b-PG complex Heteromer
A0A087WT03; P29016; Q6P4G7;
21-117
100NAG;CUY;NAG; 12×EDO;NA;D3D;ACT;CL;
Ternary crystal structure of the human NKT TCR-CD1d-C20:2 complex Heteromer
P15813;
21-117
100NAG;DB3;MG;
Crystal structure of human autoreactive-Valpha24 NKT TCR in complex with CD1d-beta-galactosylcerami… Heteromer
P01848; P15813;
21-117
100GCY;
Structure of MHC-class I related molecule MR1 Heteromer
Q95460;
21-117
1006FP;CL;PO4;
Structure of human MR1-5-OP-RU in complex with human MAIT TRBV20 TCR Heteromer
Q95460;
21-117
1002LJ;NA;
Recognition of MHC-like molecule Heteromer
Q95460;
21-117
1002LJ;NAG;
Structure of human MR1-5-OP-RU in complex with human MAV36 TCR Heteromer
Q95460;
21-117
1002LJ;
Crystal structure of ternary complex of human MR1, ligand #4, and MAIT-TCR A-F7 Heteromer
Q95460;
21-117
100A1LXU;
STRUCTURE OF THE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 Heteromer
P04439;
21-117
100
Molecular basis for tumor infiltrating TCR recognition of hotspot KRAS-G12D mutation Heteromer
C1K0Y1; P01111;
22-118
100
HLA-B*15:02 complexed with a synthetic peptide Heteromer
F4NBQ8; Q9BYJ1;
22-117
100NA;GOL;ACT;EDO;
Crystal Structure of HLA-B*37:01 in complex with NP338-L7S influenza peptide Heteromer
P01889;
21-116
100
TCR55 in complex with Pep20/HLA-B35 Heteromer
K7N5M4; P01889; Q6IRV4;
22-117
10027×GOL;PO4;
Structure of human MAIT A-F7 TCR in complex with human MR1-4'D-5-OP-RU Heteromer
Q95460;
21-116
100GOL;Q7J;NA;
Structure of human MAIT A-F7 TCR in complex with human MR1-5'D-5-OP-RU Heteromer
Q95460;
21-116
1002LJ;GOL;NA;
Structure of human MR1-2-OH-1-NA in complex with human MAIT A-F7 TCR Heteromer
Q95460;
21-116
1007WO;GOL;CL;NA;
Structure of human MAIT TCR in complex with human MR1-6-FP Heteromer
P01850; Q95460;
21-116
1006FP;
Crystal structure of TCR-MR1 ternary complex bound to 5-(2-oxoethylideneamino)-6-D-ribitylaminourac… Heteromer
P01850; Q6P4G7; Q95460;
21-116
1002L4;
The structure of human MAIT TCR in complex with MR1-K43A-RL-6-Me-7OH Heteromer
P01850; Q6P4G7; Q95460;
21-116
100GOL;1VY;
Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8, Beta Chain-TRBV7-8, Antigen-presenting gly… Heteromer
A0A0B4J279; A0A5B9; P01848; P15813;
22-117
100NAG;JLS;
Structure of human MR1-5-OP-RU in complex with human MAIT TRBV6-4 TCR Heteromer
Q95460;
21-116
1002LJ;
Structure of human MR1-5-OP-RU in complex with human MAIT C-A11 TCR Heteromer
Q95460;
21-116
1002LJ;B3P;
Structure of human MR1-5-OP-RU in complex with human MAIT B-B10 TCR Heteromer
Q95460;
21-116
1002LJ;GOL;
Structure of human MR1-5-OP-RU in complex with human MAIT C-C10 TCR Heteromer
Q95460;
21-116
1002LJ;GOL;
Structure of human MR1-5-OP-RU in complex with human MAIT B-F3-C1 TCR Heteromer
Q95460;
21-116
1002LJ;GOL;
Ternary crystal structure of the human NKT TCR-CD1d-4'deoxy-alpha-galactosylceramide complex Heteromer
P15813;
22-117
100NAG;4GH;MG;
Crystal structure of an iNKT TCR in complex with CD1d-lysophosphatidylcholine Heteromer
P15813;
22-117
100.0NAG;LSC;HEX;D12;GOL;
Crystal structure of Tapasin in complex with HLA-B*44:05 (T73C) Heteromer
D5H3J5; O15533;
23-118
100.0
Structure of an early native-like intermediate of beta2-microglobulin amyloidosis Heteromer
23-117
98.95SO4;GOL;
CD1a ternary complex with endogenous lipids and BK6 TCR Heteromer
P01848; P01850; P06126;
21-115
100.0NAG;OLA;
Structure of the Beta2_microglobulin involved in amyloidogenesis Heteromer
A2KD59;
27-117
100
Structure of echovirus 18 in complex with neonatal Fc receptor Heteromer
P55899; Q8V635;
21-84
100.0PLM;GUN;
Heterogeneous dodecamer formed from macrocycles containing a sequence from beta-2-microglobulin(63-… Heteromer
83-89
85.7113×SO4;CL;
beta-2-microglobulin V27M amyloid fibril form 4PFhomo-12-mer41-104
98.44
Two protofilament beta-2-microglobulin amyloid fibrilhomo-8-mer42-105
100
Crystal structure of Beta 2 Microglobulin amyloidogenic segment LSFSKDhomo-8-mer74-79
100
A regulatable switch mediates self-association in an immunoglobulin foldhomo-6-mer21-118
98.98CU;TLA;
beta-2-microglobulin DeltaN6 amyloid fibril form 2PFahomo-6-mer27-113
100
beta-2-microglobulin DeltaN6 amyloid fibril form 2PFbhomo-6-mer27-112
100
beta-2-microglobulin D76N amyloid fibril form 2PFahomo-6-mer26-110
98.82
Hexamer formed by a macrocycle containing a sequence from beta-2-microglobulin (63-69).homo-6-mer83-89
71.43CL;SO4;NA;
Crystal Structure of the tetrameric Beta-2 microglobulin DIMC20 mutanthomo-4-mer21-119
98.9910×CD;NA;
Crystal structure of the beta-2 microglobulin DIMC50 disulphide-linked homodimer mutanthomo-4-mer21-118
98.98PEG;PO4;
A Native to Amyloidogenic Transition Regulated by a Backbone Triggerhomo-4-mer24-117
98.94
Crystal structure of tetrameric beta-2-microglobulin deltaN6 S52C stabilized by a covalent ligandhomo-4-mer27-116
98.89TRS;SJK;
3D Structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMRhomo-4-mer40-61
100
A new V27M variant of beta 2 microglobulin induced amyloidosis in a patient with long-term hemodial…homo-2-mer21-119
98.99GOL;MG;CA;PO4;
Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.9 Angstrom resolutionhomo-2-mer21-119
98.99
Crystal structure of Beta 2 Microglobulin domain-swapped dimerhomo-2-mer21-119
100GOL;
Crystal structure of dimeric S33C beta-2 microglobulin mutant in complex with Thioflavin (ThT) at 2…homo-2-mer21-119
98.99TFX;
Crystal structure of dimeric S33C beta-2 microglobulin mutant at 1.4 Angstrom resolutionhomo-2-mer21-118
98.98
FYLLYYT segment from human Beta 2 Microglobulin (62-68) displayed on 54-membered macrocycle scaffoldhomo-2-mer81-88
87.5MPD;
Crystal Structure of the amyloid-fibril forming peptide KDWSFY derived from human Beta 2 Microglobu…homo-2-mer78-83
100PE4;NA;
HLA-A*0201 single chain trimer with HPV.16 E7 peptide LLMGTLGIVmonomer16-119
97.98
Crystal structure of beta-2-microglobulin D76G mutantmonomer21-119
98.99
Crystal structure of beta-2-microglobulin D76A mutantmonomer21-119
98.99
Crystal structure of beta-2-microglobulin D76E mutantmonomer21-119
98.99GOL;PGE;
Crystal structure of the D98N Beta-2 Microglobulin mutantmonomer21-119
98.99PGE;PEG;ACT;
Crystal structure of beta-2-microglobulin D76Y mutantmonomer21-119
98.99
The double mutant of Beta-2 microglobulin K58P-W60Gmonomer21-119
97.98PE4;
Crystal structure of the D76A Beta-2 Microglobulin mutantmonomer21-119
98.99PGE;ACT;
Crystal structure of the D76E Beta-2 Microglobulin mutantmonomer21-119
98.99PGE;
Crystal structure of the D76N Beta-2 Microglobulin mutantmonomer21-119
98.99NA;ACT;PEG;
Crystal structure of the D59N Beta-2 Microglobulin mutantmonomer21-119
98.99PEG;
Crystal structure of the D76H Beta-2 Microglobulin mutantmonomer21-119
98.99ACT;PGE;
The crystal structure of beta2-microglobulin R97Q mutantmonomer21-119
98.99ACT;
Crystal structure of beta-2-microglobulin D76Q mutantmonomer21-119
98.99
Crystal structure of the D38N Beta-2 Microglobulin mutantmonomer21-119
98.99PEG;ACT;
Crystal structure of W95L beta-2 microglobulinmonomer21-119
98.99PGE;
Crystal structure of the D53N Beta-2 Microglobulin mutantmonomer21-119
98.99PEG;ACT;
Human beta-2 microglobulin double mutant W60G-N83Vmonomer21-119
97.98GOL;ACT;PEG;
Crystal Structure of a single chain trimer composed of HLA-B*39:06 Y84C variant, beta-2microglobuli…monomer21-119
100.0EDO;GOL;CL;
Crystal Structure of a single chain trimer composed of HLA-B*39:01 Y84C variant, beta-2microglobuli…monomer21-119
100.0P4G;EDO;
Crystal Structure of a single chain trimer composed of HLA-B*39:06 Y84C variant, beta-2microglobuli…monomer21-119
100.0SO4;EDO;PEG;
The crystal structure of beta2-microglobulin D76N mutant at room temperaturemonomer21-119
98.99
Human beta-2 microglobulin mutant V85Emonomer21-119
98.99ACT;
structure of W60V beta-2 microglobulin mutantmonomer21-119
98.99
Beta 2 microglobulin mutant D59Pmonomer21-119
98.99
Crystal structure of the human beta-2 microglobulin mutant W60Gmonomer21-119
98.99
X-ray crystal structure of the N-terminal region from HCMV US11 binding to HLA-A*02:01monomer21-119
100.0GOL;
Crystal structure of Human double mutant beta2-microglobulin Q8H-L65Tmonomer21-119
97.98
Beta 2 microglobulin mutant W60Cmonomer21-119
98.99
The crystal structure of wt beta2-microglobulin at room temperaturemonomer21-119
100
CD1c in complex with MPM (mannosyl-beta1-phosphomycoketide)monomer21-119
100NAG;D12;MK0;
Protein-induced photophysical changes to the amyloid indicator dye, thioflavin Tmonomer21-119
98.99CU;
CD1c in complex with PM (phosphomycoketide)monomer21-119
100NAG;PMK;CL;MLI;
Structure of MHC-class I related molecule MR1 with bound M3Ademonomer21-119
100.0R8F;
Structure of human CD1emonomer21-119
100NAG;GOL;
NMR solution structure of the human beta2-microglobulinmonomer21-119
100
Prion-like conversion during amyloid formation at atomic resolutionmonomer21-119
100
Solution structure of W60G mutant of human beta2-microglobulinmonomer21-119
98.99
The high resolution crystal structure of beta2-microglobulin under physiological conditionsmonomer21-118
100
Crystal structure of beta-2-microglobulin D76K mutantmonomer21-118
98.98
human beta-2 microglobulin double mutant W60G-Y63Wmonomer21-118
97.96
Crystal structure of beta-2-microglobulin D76S mutantmonomer21-117
98.97GOL;
Protein induced photophysical changes to the amyloid indicator dye, thioflavin Tmonomer21-117
98.96HG;TFX;TLA;ACT;
The Crystal Structure of human beta2-microglobulinmonomer21-117
100NA;
D53P beta-2 microglobulin mutantmonomer21-117
98.97PE4;
Beta2 microglobulin mutant H31Y displays hints for amyloid formationsmonomer21-117
98.97
Crystal Structure of monomeric human beta-2-microglobulinmonomer21-116
100NA;
The Crystal Structure of human beta2-microglobulin, L39W W60F W95F Mutantmonomer21-115
96.84NA;
Prion-like conversion during amyloid formation at atomic resolutionmonomer27-119
100

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6w51.1.Bmonomer0.8521-119
100.00